Professor Yi-Ming Arthur Chen

陳 宜 民 教授

400230 56dbd855d926f384 o

 

Current Position

Yi-Ming A. Chen M.D., M.S., Sc.D.

Vice President,

Director, Center for Infectious Disease and Cancer Research (CICAR)

Professor, Department of Microbiology,

College of Medicine,
Kaohsiung Medical University
KaohsiungCity

Taiwan

Email: arthur@kmu.edu.tw

Jointed appointment

Institute of Medical Research, KaohsiungMedicalUniversity

                                                       

Crossed appointments

Research member                    National Institute of Infectious Diseases and Vaccinology

                                                National Health Research Institute

                                                Taiwan

Adjunct Professor                   Institute of Clinical Medicine, NationalYang-MingUniversity

Adjunct Professor                 Institute of Microbiology and Immunology, NationalYang-MingUniversity

Adjunct professor                   Department of Public Health,

College of Public Health and Nutrition,

TaipeiMedicalUniversity

Education

1975-1982          M.D., Department of Medicine, National Yang-Ming Medical College, Taiwan

1982-1984          M.S., Institute of Microbiology and Immunology, NYMU, Taiwan

1986-1990          Sc.D., Department of Cancer Biology (Infectious Disease and Immunity), Harvard School of Public Health, Boston, MA, USA       

Working experiences

1982-1984       Teaching Assistant, Department of Microbiology and Immunology, NYMU, Taiwan

1984-1986       Aviation Doctor, Air-forceGeneralHospital, (Military services), Taiwan

1986                Lecturer, Department of Microbiology and Immunology, NYMU

1990-1992       Visiting Scientist, Lab of Molecular Oncology, National Cancer Institute, USA

1992-1998       Associate Professor,  Institute of Public Health, NYMU, Taiwan

1992-1994       Associate Research Member, Institute of Biomedical Sciences, Academia Sinica, Taiwan

1993-1995       Director, Section of Extra curriculum, Office of Student Affairs, NYMU

1994-1997       Chairman, Institute of Public Health

2000-2005       Chairman, Institute of Public Health

1998-2007       Professor, Institute of Public Health, NYMU, Taiwan

2002-2003       Visiting Scientist, HIV Drug Resistance Program, NCI, USA

2007-2009       Professor, Department of Microbiology and Immunology, NYMU

2009-2012       Distinguished Professor, Department of Microbiology and Immunology, NYMU

2007-2010       Dean, Office of International Affairs, NYMU

2008-2010       Director, International Health Program, NYMU

2010-2011       Dean, Office of Research and Development, NYMU

2010-2011       Director, Office of Research Centers, NYMU

Advisory committee, steering committee and society

1992-2004    Member, AIDS Advisory Committee, Centers of Disease Control, Ministry of Health, Taiwan

2004-2012    Member, Committee for AIDS Prevention and HIV-infected People’s Rights Protection, Executive Yuan, Taiwan

2012-2014    Member, Illegal Drug Evaluation Committee, Ministry of Legal Affairs, Executive Yuan, Taiwan

1994-2012    Founder and Coordinator, Living with Hope Organization

1993-2012  Board Member, Taiwan Society of Preventive Medicine (has been elected as secretary general in 1993-1996, as chairman in 1997-2003)

1996-2012    Board member, Taiwan AIDS Hope Association (Founder)

1998-2012     Council of Representative, Asia Pacific AIDS Services Organization

2007-2012     Consultant, Anti-drug Usage Committee, Tao-Yuan Prefecture, Taiwan

2007-2012     Consultant, TaipeiCity Government

1996-2006     Advisory Board on Health Issues, Consumer Foundation, Taiwan

2001-2010    Member, AIDS Education Advisory Committee, Ministry of Education, Taiwan

2004-2009     Member, Steering committee, Therapeutic Research, Education and AIDS Training in Asia (TREAT Asia) (served as the chairman 2008-09)

2001-2003Regional Task Force on HIV/AIDS Care and support in Asia

2002-2005         Vice Chairman, Global Chinese AIDS Network (co-founder)

2008-2010     Vice Chairman, Global Chinese AIDS Network

2001                            Medical Advisory Board, OmniViral Therapeutics LLC

2005-2007     Chairman, Taiwan AIDS Quilt Association (Founder)

2006-2009     Board member, Harmony Home Association

2003-2009     Board member, Taiwan Society of Epidemiology

2007-2010     Chairman, Taiwan Harm Reduction Association 

2006-2009     Consultant, Centers for Disease Control, Taiwan

2008-2012     Board Member, Taiwan Can Love AssociationCo-founder

2008-2009     TREAT Asia Steering Committee Chair

2009             Committee Member, Global Vaccine Access Council (University of WesternOntario, Canada)

2008-2012     Board Member, Taiwan Society of Microbiology

2008-2012    Managing Supervisor, Taiwan Society of Preventive Medicine

2010-2012  Board Member, Taiwan Society of Microbiology, Taiwan

2010-2012    Chairman, Microbiology field, National Examination for Medical Board, Examination Yuan of ROC. (考試院醫師國家考試,微生物學門召集人).

2012-2013    Committee member, Illegal Drug Examination and Determination Committee, Ministry of Justice, ROC. (法務部毒品審議委員會委員)

2012              考試院101年公務人員高等考試一級暨二級考試審查委員

Honors and awards

  1. Scholarship from Society of Microbiology of ROC, Yen Shi-Chung Award, 1983.
  2. Scholarship from the Ministry of Education to study abroad, Taiwan, R.O.C., 1986-89.
  3. Scholarship from the FogartyInternationalCenter, National Institutes of Health, Program of International Training Grants 1989-92.
  4. Education and Culture Award, Significant Contribution to the Scientific Education for the Public, from the Ministry of Education, Taiwan, 1993.
  5. Research award, from the National Science Council, Taiwan, 1993, 1994, 1995, 1997, 1999 and 2000.
  6. Secretary General, the First, Second and Third Taipei International AIDS Conferences, 1990, 1992 and 1994.
  7. Candidate for the International Prince Mahidol Award from Thailand, nominated by the Department of Health, Executive Yuan, R.O.C., 1994.
  8. Young Investigator Award, First Joint Annual Conference of the Society of Oncology, Taiwan, 1996.
  9. Who’s Who in the World, 2001- 18th edition.
  10. Who’s Who in Medicine and Healthcare, 2002 edition.
  11. Who’s Who among Executives and Professionals, 2010 edition.
  12. Scholarships from the National Science of Council of ROC for short-term training (2003).
  13. Outstanding Research Award from National Science Council, 2008. 97年度國科會傑出研究獎)
  14. Outstanding alumnus, Fu-XinPrimary school, 2004.
  15. Best Paper Award from the Urbani Foundation 2005 and 2007.
  16. Award to Special contribution to harm reduction program, 2007, Ministry of Health. (衛生署減害計畫特殊貢獻獎)
  17. The Second Best Research Paper Award of the Chinese Medical Association Annual meeting, 2007.
  18. The Best Research Paper Award of the TaipeiCityHospital grants, 2007.
  19. Outstanding alumnus (Academic achievement), National Yang-Ming University, 2009 (陽明大學第六屆學術類傑出校友獎).
  20. The 8th National Innovation Award (國家新創獎) in the Academic Research Category by Institute for Biotechnology and Medicine Industry, 2011.
  21. Award of the “Science Tour-Health Research inGermany” from German Academic Exchange Service, 2011.
    1. United States Patent: Detection and Correction of Abnormalities of Cells having Decreased Levels of Glycine N-methyltransferase. Patent number: 5994093 (1999/11/30-Nov. 30, 2019/11/29).
    2. ROC Patent: Detection and Correction of Abnormalities of Cells having Decreased Levels of Glycine N-methyltransferase. Patent number: 086114505  (Duration: 1997/10/4-Oct. 4, 2017/10/3).
    3. United States Patent: Glycine N-methyltransferase monoclonal antibodies and methods of use therefore. Patent number:7176291 (Duration: 2007/2/13-2027/2/12).
    4. United States Patent: Glycine N- methyltransferase (GNMT) animal model and use thereof. Patent number: US7759542 (Duration: 2007/8/1-2027/7/31).
    5. China Patent:甘氨酸N-甲基轉移酶在製備預防或治療黃麴霉素所引發的疾病的藥物中的應用. Patent number: 200810008673.6 (Duration: Jan. 29, 2008/1/29- 2027/1/28).
    6. ROC patent:一種與憂鬱症、精神分裂症和阿茲海默症有關的小鼠動物模式. Patent No. P-090035-TW (duration: 2012/9/12-2032/9/12).
    7. A mouse model for depression, schizophrenia and Alzheimer’s disease. Under review (Patent under application in US and Europe).
    8. 抗NPC2蛋白之單株抗體以及利用其檢測脂肪肝、癌細胞或癌組織的方法. (Patent under application).
    9. Chen YM, Hu CP, Wong FH, et al.  Circulating immune complexes in the sera and ascites of hepatocellular carcinoma patients. Chinese J. Micro. Immunol. 19: 34-45, 1986.
    10. Chen YM, Hu C, Chen P, et al. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients. Hepatology 8: 547-552, 1988.
    11. Matsuda Z, Chou MJ, Matsuda M, Huang JH, Chen YM, Redfield R, Mayer K, Essex M and Lee TH. Human immunodeficiency virus type 1 has an additional coding sequence in the central region of the genome. Proc. Natl. Acad. Sci., USA 85: 6968-6972, 1988. 
    12. Chen YM, Lee TH, Samuel KP, Okayama A, Tachibana N, Miyoshi I, Papas TS, and Essex M.  Antibody reactivity to different regions of human T-cell leukemia virus type-I (HTLV-I) gp61 in infected people. J. Virol. 63: 4952-4957, 1989.
    13. Chen YM, Lee TH, Wiktor SZ, Shaw GM, Murphy EL, Blattner WA and Essex M. Type-specific antigens for serological discrimination of HTLV-I and II infection. Lancet 336: 1153-1155, 1990.
    14. Chen YM, Gomez-Lucia E, Okayama A, Tachibana N, Lee TH, Mueller N and Essex M.  The antibody profile of early HTLV-I infection. Lancet 336: 1214-1216, 1990.
    15. Okayama A, Chen YM, Tachibana N, Shioiri S, Lee TH, Tsuda K and Essex M.  High incidence of antibodies to HTLV-I tax in blood relatives of adult T-cell leukemia patients. J. Infect. Dis. 163: 47-52, 1991.
    16. Chen YM, Okayama A, Lee TH, Tachibana N, Mueller N and Essex M. Sexual transmission of HTLV-I associated with the presence of the anti-tax antibody.  Proc. Natl. Acad. Sci. USA 88: 1182-1186, 1991. 
    17. Chen YM and Essex M. Identification of a recombinant HTLV-II envelope protein with distinguishing reactivities to sera from HTLV-II carriers. AIDS Res. Hum. Retroviruses 7: 453-457, 1991.
    18. Chen YM, Zhang X-q, Dahl C, Samuel KP, Schooley RT, Essex M and Papas TS. Delineation of type-specific regions on human T-cell leukemia virus envelope glycoproteins. J. Immunol. 147: 2368-2376, 1991.
    19. Chen YM*. Serological discrimination of HTLV-I and HTLV-II infection by recombinant protein-western blot assays. Biomed. Pharmacotheraphy 45: 274, 1991.
    20. Okayama A, Kober B, Chen YM, Allan J, Lee TH, Shioiri S, Tachibana N, Tsuda K, Mueller N, Mclane MF, Maayan S, Markink R, Orgad S and Essex M. Unusual pattern of antibodies to HTLV-I in family members of adult T-cell leukemia patients. Blood 78: 3323-3329, 1991.
    21. Samuel KP, Hodge DR, Chen YM and Papas TS. Nef protein of the human immunodeficiency viruses (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV) are structurally similar to leucine zipper transcriptional activation factors. AIDS Res. Hum. Retroviruses 7: 697-706, 1991.
    22. Zhang X-q, Yang L, Ho DD, Kuritzkes D, Chen I, Chen YM and Schooley RT. HTLV-I and HTLV-II Specific antibody dependent cellular cytotoxicity: strain specificity and epitope mapping. J. Infect. Dis. 165: 805-812, 1992.
    23. Maayan S, Dan M, Marlink R and Chen YM*. Exposure to Human Retroviruses HTLV-I, HTLV-II and HIV among Israeli IV drug abusers. Int. J. Epidemio. 21: 995-997, 1992.
    24. Whang-Peng J, Chen YM, Knutsen T, Zhao W-P and Tsai S. Chromosome studies in HTLV-I, II, and HIV-1, 2 cell lines infected in vivo and in vitro. J. Acqui. Immun. Defic. Syndr.( JAIDS) 6: 930-940, 1993.
    25. Chen YM*, Jang Y-J, Kanki PJ, Wang J-J, Montali RJ, Samuel KP and Papas TS. Isolation and characterization of simian T-cell leukemia virus type II from New World monkeys. J. Virol. 68: 1149-1157, 1994.
    26. Hodge DR, Chen YM and Samuel KP. Oligomeraization of the HIV-2 Nef Protein: mutational analysis of the heptad leucine repeat motif and cysteine residues. AIDS Res. Hum. Retroviruses 11: 65-79, 1995.
    27. Chen YM. Taiwan's sex-workers have less than 1% infection. AIDS Analysis Asia 1: 2 1995.
    28. Chang L-J, Chen YM, Chen, M-Y, Chou C-C, Twu SJ, Huang L-M. HIV 10 years later-where do we stand now? J. Biomed. Sci. 2: 1-11, 1995.
    29. Yao C, Wang W-W, Chung Y-M, Su Y-L, Liu C-Y and Chen YM*. Transfusion-acquired AIDS in Taiwan. J. Formos. Med. Assoc. 95: 51-55, 1996.
    30. Chen YM*, Lin H-C and Chou P. A population-based epidemiological study of human T-cell leukemia virus type I infection in Kin-Hu, Kinmen. Int. J. Cancer 59: 569-573, 1996.
    31. Yao C, Kao S-S, and Chen YM*. Cost-benefit analyses of the HIV-1 and HIV-1/HIV-2 screening program in blood donation centers in Taiwan. Chin. J. Public Health (Taipei) 15: 483-496, 1996.
    32. Chang P, Liau M-Y, Yang C-M, Ho M-S, Lee C-H, Chen YM and Horng C-B. Cost analysis of establishing the capability of producing MMR, DTaP, HBV, and OPV vaccines in Taiwan. Chin. J. Public Health (Taipei) 15: 517-524, 1996.
    33. Chen YM*, Chang L-Y, Fu C-Y and Chou P. A survey of knowledge, attitudes and practices (KAP) concerning AIDS among female sex workers from massage parlors in Taiwan. Chin. J. Public Health (Taipei) 16: 439-454, 1997.
    34. Shieh B, Lee C-M, Su I-J, Chen YM and Li C. Molecular subtyping of the V3 loop sequences detected in HIV-1-positive patients at the National Cheng Kung University Hospital. Chinese J. Micro. Immunol. 30: 46-54, 1997.
    35. Li C, Yan Y-P, Shieh B, Lee C-M, Lin R-Y, and Chen YM*. Analysis of the CKR5 allele in AIDS patients and female sex workers in Taiwan. J. Formos. Med. Assoc. 96: 979-984, 1997.
    36. Chen YM*, Chen S-H, Chen J-Y and Osame M. Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I infected people with differing clinical status. Int. J. Cancer 71:196-202, 1997.
    37. Chen Y-J, Shih L-S, Chang J-G, Whang-Peng J, and Chen YM*. Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. Int. J. Cancer 71: 350-354, 1997.
    38. Chen YM*, Yu PS, Lin C-C and Jen I. Surveys of HIV-1 HTLV-I and other sexually transmitted diseases among female sex workers in Taipei city and prefectures, Taiwan from 1993 to 1996. JAIDS J. Acquir. Immun. Defic. Syndr. Hum. Retrovirol. 18: 299-303, 1998.
    39. Chen YM*, Lee C-M, Lin R-Y, Chang H-J. Molecular epidemiology and Trends of HIV-1 Subtypes in Taiwan. JAIDS J. Acquir. Immun. Defic. Syndr. Hum. Retrovirol. 19: 393-402, 1998.
    40. Chen YM*, Shiu J-Y, Tzeng SJ, Li-Sun Shih, Yi-Jen Chen and Lui W-Y. Characterization of the glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int. J. Cancer 75: 787-793, 1998.
    41. Chen Y-J, ShihL-S and Chen YM*. Quantitative analysis of CDKN2, p53 and retinoblastoma mRNA in human gastric carcinoma. Int. J. Oncol. 13: 249-254, 1998.
    42. Chen YM*, Lin R-H, Lee C-M, Fu C-Y, Chen S-C and Syu W-J. Decreasing levels of anti-Nef antibody correlate with increasing viral loads and AIDS disease progression. AIDS Res. Human Retroviruses 15: 43-50, 1999.
    43. Chen YM*, Ting S-T, Lee C-M, W-T Liu, Pan W-H, TA Chang, Chou P. Community-based molecular epidemiology of human T-cell leukemia virus type I infection in Taiwan and Kinmen: Implication of the origin of the cosmopolitan subtype in North East Asia. AIDS Res. Human Retroviruses 15: 229-237, 1999.
    44. Liou YM, Chou P, Chen YM*. Genotypic Analysis of HCV infection in Kinmen. J. Microbiol. Immunol. Infect. 33: 63-68, 2000.
    45. Chen YM*, Chen LY, Wong FH, Lee CM, Chang TJ, Yang-Feng TL. Genomic structure, expression and chromosomal localization of the human glycine N-methyltransferase gene. Genomics 66: 43-47, 2000.
    46. Chen YM*, Huang KL, Jen I, Chen SC, Liu YC, Chuang YC, Wong JC,Tsai JJ. Temporal trends and molecular epidemiology of HIV-1 Subtypes in Taiwan from 1988 to 1998. J. Acquir. Immun. Defic. Syndr. Hum. Retrovirol.(JAIDS) 26: 274-282, 2001.
    47. Chen YM*, Rey WY, Lan YC, Lai SF, Huang YC, Wu SI, Liu TT, Hsiao KJ. Antibody reactivity to HIV-1 Vpu in HIV-1/AIDS patients on highly active antiretroviral therapy. J. Biomed. Sci. 10: 266-275, 2003.
    48. Yang MH, Chen YM, Kuo BI, WangKY. Quality of life and related factors for people living with HIV/AIDS in Northern Taiwan. J. Nurs. Res. 11: 217-26, 2003.
    49. Liu HH, Chen KH, Shih YP, Lui WY, Wong FH, Chen YM*. Characterization of reducedexpression of glycine N-methyltransferase in the cancerous hepatic tissues using two newly developed monoclonal antibodies. J. Biomed. Sci. 10: 87-97, 2003.
    50. Tseng TL, Shih YP, Huang YC, Wang CK, Chen PH, Chang JG, Yeh KT, Chen YM*, Buetow K. Genotypic and phenotypic characterization of a putative tumor susceptibility gene, GNMT, in liver cancer. Cancer Res. 63: 647-654, 2003.
    51. Chen SY, Lin JR, Darbha R, Liu TY, Lin CH, Chen YM*. Glycine N-Methyltransferase tumor susceptibility gene in the Benzo(a)pyrene-detoxification pathway. Cancer Res. 64: 3617-3623, 2004.
    52. Lan YC, Liu HF, Shih YP, Yang JY, Chen HY, Chen YM*. Phylogenetic analysis and sequence comparisons of structural and non-structural SARS coronavirus proteins in Taiwan. Infect. Genetic. Evolu. 5: 261-269, 2005.
    53. Lan YC, Liu TT, Yang JY, Chen YJ, Lu JJ, Chan YJ, Liu HF, Chen HY, Suing CA, Hsiao KJ, Ho MS, Chen YM*. Molecular epidemiology of SARS coronavirus infection in Taiwan. J. Infect. Dis. 191: 1478-1489, 2005.
    54. Huang CY, Sun CT, Hsieh JL, Chen YM, Lin H. A novel small-world model: using social mirror identities for epidemic simulations. Simulation 81: 671-699, 2005.
    55. Zhou J, Kumarasamy N, Zhang F, Zhao H, Han N, Li P, Lee MP, Chen YM, Wong WW, Wang DCC, Anand S, Cecelia JA, Pujari S, Joshi K, Lee CKC, Kaur S, Kamarulzaman A, Ditangco R, Capistrano R, Paton NI, Yap M, Phanuphak P, Siangphe U, Khongphattanayothing M, Vibhagool A, Kiertiburanakul S, Kiatatchasai W, Chuah J, Fankhauser W, Dickson B, Frost K, Wong S, Cooper DA, Law MG, Petoumenos K. Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: Preliminary results from the TREAT Asia HIV Observational Database (TAHOD) .HIV Med. 6: 216-223, 2005.
    56. Chen WJ, Yang JY, Lin JH, Fann CSJ, Osyetrov V, King CC. Chen YM, H. L. Chang HL, Kuo HW, F. Liao F, Ho MS.  Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms. Clin. Infect. Dis. 42: 1561-1569, 2006.
    57. Chen, YM*, Liang SY, Chu DC, Lee YM, Chang L, Jung SY, Chen HY, Chjan YJ, Ho MS, Liang KY, Jang Y-J, Chu T-C. Epidemiological and genetic correlates of SARS coronavirus infection in a hospital with the highest nosocomial infection rate in Taiwan in 2003. J. Clinc. Microbio. 44: 359-365, 2006.
    58. Hsieh YH, Lee SM, Chen CW-S, Chen YM, Wu S-I, Lai SF. Estimating the HIV-1-infected population size within hard-to-count MSM groups: the case of gay saunas patrons in Taipei area. Physica. A. 362: 495-503, 2006.
    59. Chen YM*, Lan YC, Lai SF, Yang JY, Tsai SF, Kuo HS. HIV-1 CRF07_BC infections, injecting drug users, Taiwan. Emerg. Infect. Dis. 12: 703-705, 2006.
    60. Lee CM, Chen SY, Lee YCG, Huang CYF, Chen YM*. Benzo[a]pyrene and glycine N-methyltransferse interactions: Gene expression profiles of the liver detoxification pathway. Toxicol. Appl. Pharmacol. 214: 126-135, 2006.
    61. Chiu HC, Wang FD, Chen YM, Wang CT. Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing. J. Gen. Virol. 87: 2041-2046, 2006.
    62. Qiu JT, Chang TC, Lin CT, Chen YM, Li F, Soong YK, Lai CH. Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag. Vaccine. 25(2):253-263, 2007.
    63. Shih YP, Chen CY, Liu SJ, Chen KH, Lee YM, Chao YC, Chen YM.*Identifying Epitopes Responsible for Neutralizing Antibody and DC-SIGN Binding on the Spike Glycoprotein of the Severe Acute Respiratory Syndrome Coronavirus. J. Virol. 80: 10315-10324, 2006.
    64. Hsu CH, Hwang KC, Chao CL, Chang SGN, Ker CC, Chien LC, Ho MS, Lin JG, Chen YM, Chou P. The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients. Am. J. Chin. Med. 34: 6927-6935, 2006.
    65. Zhou J, Paton NI, Ditangco R, Chen YM, A Kamarulzaman, N Kumarasamy, CKC Lee, PCK Li, TP Merati, P Phanuphak, S Pujari, A Vibhagool, F Zhang, J Chuah, KR Frost, DA Cooper and MG Law. Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database. HIV Med. 8: 8-16, 2007.
    66. Coulibaly S, Yen PMN, Fu LA, Chen YM*. Needs assessment of people living with HIV/AIDS in Taiwan. Taiwan
    67. Huang YC, Lee CM, Shih YP, Chung MY, Chang YH, Huang JSW, Ho MTD, Pan CC, Wu TL, Hsu JM, Yang S, Lin MW, Chen YM.* Haplotypes, loss of heterozygosity and expression levels of glycine N-methyltransferase gene in prostate cancer. Clin. Cancer Res. 13: 1412-1420, 2007.
    68. Chen YM* and Kuo HS. HIV-1 inTaiwan. Lancet 369: 623-625, 2007. (has been chosen as the Article of the Month, April 2007 by the International Harm Reduction Association).
    69. Lin YT, Lan YC, Chen YJ, Liu TT, Yang JY, Wong WW, Wang CT, Chen YM.* Molecular epidemiology and full-length genomic analysis of HIV-1 circulating recombinant form 07_BC strains from injecting drug users in Taiwan. J. Infect. Dis. 195: 1283-1293, 2007.
    70. Huang YC, Chung MY, Chang YH, Huang JSW, Wu TL, Hsu JM, Yang S, Lin MW, Chen YM.* The CYP19 TCT Tri-Nucleotide Del/Del Genotype is a Susceptibility Marker for Prostate Cancer in a Taiwanese Population. Urology 69: 996-1000, 2007.
    71. Lien SP, Shih YP, Lien S, Tsai JP, Leng CH, Chen HW, Lin MH, Liu SY, Chen YM, Chong P, Liu SJ. Identification of synthetic vaccine candidates against SARS CoV infection. Biochem. Biophys. Res. Commun. 358: 716-721, 2007.
    72. Chen CY, Ping YH, Lee HC, Chen KH, Lee YM, Lian DC, Jap TS, Lin CH, Kao LS, Chen YM.*Open reading frame 8a of the human severe acute respiratory syndrome coronavirus not only promotes viral replication but also induces apoptosis. J. Infect. Dis. 196: 405-415, 2007.
    73. Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM*. Hepatitis B and C virus coinfection in the TREAT Asia HIV Observational Database. J. Gastroent. Hepatol. 22: 1510-1518, 2007.
    74. Medah I, Lai SF, Chuang SY, Chang CL, Yen PM N, Chen YM*. Knowledge, attitude, and practices towards human immunodeficiency virus type 1 infection among new entrant university students in Taiwan. Taiwan J. Public Health 26: 324-337, 2007.
    75. Liu SP, Li YS, Chen YJ, Chiang EP, Li AFY, Lee YH, Tsai TF, Hsiao M, Huang CF, Chen YM.* Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in liver. Hepatol. 46: 1413-1425, 2007.
    76. Goka EAC, Yen PMN, Chiou JQ, Lin CL, Wu CM, Fan HH, Chen YM*. Knowledge attitudes and practice of antenatal mothers on HIV/AIDS and their satisfaction with PMTCT program in Taiwan. Int. J. Coop. 2: 65-88, 2007.
    77. Lan YC, Elbeik T, Dileanis J, Ng V, Chen YJ, Leu HS, Cheng SH, Wong JC, Wong WW, Chen YM*. Molecular epidemiology of HIV-1 subtypes and drug resistant strains in Taiwan. J. Med. Virol. 80: 183-191, 2008.
    78. Huang YC, Chen M, Li AFY, Su CH, Shyr YM, Ho DMT, Chen YM*. Glycine N-methyltransferase is a favorable marker for human cholangiocarcinoma. . 23:1384-1389, 2008. (Epub 2008 Jul 8.)
    79. Wang SF, Huang JC, Lee YM, Liu SJ, Chan YJ, Chau YP, Chuang P, Chen YM*. DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem. Biophys. Res. Commun. 373: 561-566, 2008. (Epub 2008 Jun 30.)
    80. Chuang PC, Liu H, Sola C, Chen YM, Jou R. Spoligotypes of mycobacterium tuberculosis isolates of a high tuberculosis burden aboriginal township in Taiwan.
    81. Liao, YJ, Liu SP, Lee CM, Yen CH, Chuang PC, Chen CY; Tsai TF; Huang SF, Lee-Wu Yan-Hwa, Chen YM*. Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma. Int. J. Cancer 124: 816-826, 2009. (Epub Sep 2008).
    82. Yen CH, Hung JH, Liu SP, Chen SY,Chou TY, Tsai TF, Darbha R,Hsieh LL, ChenYM*. Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect. Toxicol. Appl. Pharmacol. 235: 296-304, 2009. (Epub December 2008).
    83. Wang SF, Chen KH, Thitithanyanont A, Yao L, Lee YM, Chan YJ, Liu SJ, Chong P, Liu WT, Huang JC, Chen YM.* Generation and Characterization of Monoclonal and Polyclonal Antibodies against Avian H5N1 Hemagglutinin Protein. Biochem. Biophys. Res. Commun. 382: 691-696, 2009.
    84. Lee CM, Shih YP, Chen YM*. Characterization of the 5' Regulatory Region of the Human Glycine N-methyltransferase Gene. Gene 443: 151-157, 2009.
    85. Chen M, Huang YC, Ko IL, Yang S, Chang YH, Huang W J-S, Chen YM*. The rs1447295 at 8q24 is a risk variant for prostate cancer in Taiwanese men. Urology 74: 298-301, 2009.
    86. Wang SF, Huang JC, Lee YM, Liu SJ, Chan YJ, Chau YP, Chuang P, Chen YM*. Influenza A virus in Taiwan, 1980-2006: Phylogenetic and antigenic characteristics of the hemagglutinin gene. J. Med. Virol. 81: 1457-1470, 2009.
    87. Zhou J, Elliott J, Li PCK, Lim PL, Kiertiburanakul S, Kumarasamy N, Merati TP, PUjari S, Chen YM, Phanuphak P, Vonthanak S, Sirisanthana T, Sungkanuparph S, Lee CKC, Kamarulzaman A, Oka S, Zhang F, Tau G Ditangco R. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis. 9: 46-55, 2009
    88. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N , Zhou J, Saphonn V, Zhang FJ, Li PCK, Pujari S, Merati TP, Oka S, Choi JY, Lee C KC, Kamarulzaman A, Tau G, Ditangco R, Chen YM, Phanuphak P, Sungkanuparph S, Sirianthana T, Smith Jand Law M G. Short-Term Clinical Disease Progression in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT Asia HIV Observational Database. Clin. Inf. Dis. 48: 940-950, 2009.
    89. Land S, Cunningham P, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M. The TREAT Asia quality assessment scheme to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories. J. Virol. Meths. 159: 185-193, 2009.
    90. Chen YM*, Liao YJ, Liu SP, Tsai TF. Phenotypic difference of two GNMT-/- mouse model for hepatocellular carcinoma. Hepatology 2009; 2130-2131, 2009.
    91. Lee YM, Wang SF, Chan YJ, Chen YM*. 2006-2007 Outbreak of reassortant influenza B virus in north Taiwan. BMJ Res. Note 2: 85-96, 2009.
    92. Chen YM*, Yen CH, Liu SP, Liao YJ. Response to the letter to the editor from Dr. Conrad Wagner. Toxicol. Appl. Pharmacol. 237: 247, 2009.
    93. Huang JC, Chang YF, Chen KH, Lee CW, Su LC, Chen CC, Chen YM*, Chou C*. Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Human Serum using a Localized Surface Plasmon Coupled Fluorescence Fiber-optic Biosensor. Biosens. Bioelectron. 25: 320-325, 2009.
    94. Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, Shih YH, Hung SC, Fu YS. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton;s jelly in the treatment of rat liver fibrosis. Liver Transplant. 15: 484-495, 2009.
    95. Pujari S , Srasuebkul P, Sungkanuparph S, Lim PL, Kumarasamy N, Chuah J, Kumar RN, Chen YM, Oka S, Choi JY, Lee MP, Phanuphak P, Kamarulzaman A, Lee C, Fujie Z, Ditangco R, Saphonn V, Sirisanthana T, Parwati T, Merati, Smith J, Law MG. Patient characteristics and treatment outcome associated with Protease Inhibitor (PI) use in the Asia-Pacific region. J. Antimicrobiol. Chemother. 1: 28-35, 2009.
    96. Peng EYC, Lee MB, Morisky DE, Yeh CY, Farabee D, Lan YC, Chen YM, Lyu SY*. Psychiatric morbidity in HIV-infected male prisoners. 109: 177-84, 2010.
    97. Tsai MJ, Chen YM, Weng CF, Liou DY, Yang HC, Chen CH, Liao RI, Kuo FS, Chiu CW, Kuo HS, Huang MC, Lin YL, Lee MJ, Kuo WC, Huang WC, Cheng H. Enhanced expression of glycine N-methyltransferase by adenovirus-mediated gene transfer in CNS culture is neuroprotective. Ann. N. Y. Aca. Sci. 1199: 194-203, 2010.
    98. Lee YM, Lin HJ, Lee CM, Chen YJ, Chen YM*. Molecular Epidemiology of HCV Genotypes among Injection Drug Users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. J. Med. Virol. 82: 57-68, 2010.
    99. Chen M, Huang YC, Ko IL, Yang S, Chang YH, Huang W J-S, Yi-Ming Arthur Chen YM*. Common variants at 8q24 are associated with prostate cancer risk in Taiwanese men. Prostate, 70: 502-507, 2010. [2009 Nov 11. Epub ahead of print]
    100. Chan YJ, Lee CL, Hwang SJ, Fung CP, Wang FD, Yen DHT, Tsai CH, Chen YMA, Lee SD. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J. Chin. Med. Assoc. 73: 62-66, 2010.
    101. Liao YJ, Chen KH, Huang SF, Chen TL, Wang CK, Chien CH, Tsai TF, Liu SP, Chen YM.* Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver. Proteomics Clin. Appl. 4: 394-406, 2010.
    102. Chen YJ, Huang YH, Kao DYT, Lan YC, Yang JY, Chen YM*. Molecular epidemiology of subtype B, CRF01_AE and CRF07_BC infection among injection drug users in Taiwan. J Acquir Immune Defic Syndr (
    103. Oyomopito R, Lee MP, Phanuphak P, Lim PL, Citangco R, Zhou J, Sirianthana T, Chen YM, Pujar S, Kumarasamy N, Sungkanuparph S, Lee CKC, Kumarulzaman A, Oka S, Zhang FJ, Mean CV, Merati TP, Tau G, Li PCK. Measures of country and site resourcing predict virologic suppression, immunologic response and HIV disease progression following HAART in the TREAT Asia HIV Observational Database (TAHOD). HIV Med. 11: 519-529, 2010.
    104. Zhou J Pujari S , Srasuebkul P, Sungkanuparph S, Lim PL, Kumarasamy N, Chuah J, Kumar RN, Chen YM, Oka S, Choi JY, Lee MP, Phanuphak P, Kamarulzaman A, Lee C, Fujie Z, Ditangco R, Saphonn V, Sirisanthana T, Parwati T, Merati, Smith J, Law MG. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from The TREAT Asia HIV Observational Database (TAHOD) HIV Med. 11: 31-39, 2010.
    105. Chang YF, Wang SF, Huang JC, Su LC, Yao L, Li YC, Wu SC, Chen YM, Hsieh JP, Chou C. Detection of swine-origin influenza A (H1N1) viruses using a localized surface plasmon coupled fluorescence fiber-optic biosensor.
    106. Peng EY, Yeh CY, Lyu SY*, Morisky DE, Chen YM, Lee MB, Farabee D, Malow R. Prevalence and correlates of lifetime suicidal ideation among HIV-infected male inmates in Taiwan. AIDS Care 22: 1212-1220, 2010.
    107. Wang SF,Yao L,Liu SJ,, Chong P, Chen YM*, Huang JC*.. Identifying Conserved DR1501-Restricted CD4+ T-Cell Epitopes in Avian H5N1 Hemagglutinin Proteins. Viral. Immuno. 23:585-593, 2010.
    108. Chuang PC, Chen HY, Chen YM, Jou R. Single nucleotide polymorphisms of cell wall biosynthesis associated genes and a phylogeny of principal genetic group 1 Mycobacterium tuberculosis complex. Infect. Genet. Evol. 10: 459-466, 2010.
    109. Tsai TI, Chen IJ, Morisky D, Chen YM*. Service modalities and attitudes as keys in needle exchange programmes- a survey of service providers. J. AIDS Pre. Care, 22: 546-557, 2010.
    110. Fan APC, Kuo HCC, Kao DYT, MoriskyDE, Chen YM*. Quality of life and needs assessment on people living with HIV and AIDS in Malawi. AIDS Care. 23: 287-302, 2010.
    111. Chang YJ, Chen HC, Lee BH, You SL, Lin CY, Pan MH, Chou YC, Hsieh CY, Chen YM, Cheng YJ, Chen CJ. Unique variants of human papillomavirus genotypes 52 and 58 and risk of cervical neoplasia.
    112. Chen CC, Kruger J, Sramala I, Hsu HJ, Henklein P, Chen YM, Fischer WB. Open Reading Frame 8a of SARS-CoV forms an ion channel: experiments and molecular dynamics simulations. Biochim. Biophys. Acta. 1808: 572-579, 2011.
    113. Liao CF, Wang SF, Lin YT, Ho David and Chen YM*. Identification of the DC-SIGN-interactive domains on the envelop glycoprotein of HIV-1 CRF07_BC. AIDS Res. Human Retro. 27(8):831-9 2011 Jan 17. [Epub ahead of print]
    114. Oyomopito R, Phanuphak P, Sungkanuparph S, Kumarasamy N, Sirisanthana T, Li P, Kantipong P, Lee C, Kamarulzaman A, Chen YM*. Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. .Int J Epidemiol.41: 43–54.2012;[Epub ahead of print].
    115. Petoumenos K,Hui E,Kumarasamy N,Kerr SJ,Choi JY,Chen YM,Merati T,Zhang F,Lim PL,Sungkanuparph S,Pujari S,Ponnampalavanar S,Ditangco R,Lee CK,Grulich A,Law MG;TREAT Asia HIV Observational Database. Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
    116. Zhou J,Sirisanthana T, Kiertiburanakul S, Chen YM,Han N,Lim PL,Kumarasamy N, Choi JY,Merati TP,Yunihastuti E, Oka S, Kamarulzaman A,Phanupak P, Lee CK, Li PC,Pujari S,Saphonn V, Law MG. Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database. BMC Infect. Dis. 10: 361, 2010.
    117. Liu SP, Li YS, Lee CH, Liao YJ, Huang SF, Chen CH, Chen YM*. Higher susceptibility to aflatoxin B(1)-related hepatocellular carcinoma in glycine N-methyltransferase knockout mice. Int. J. Cancer. 128: 511-23, 2011.
    118. Wang YC, Chen YM, Lin YJ, Liu SP, Chiang EP. GNMT expression increases hepatic folate contents and folate-dependent methionine synthase-mediated homocysteine remethylation. Mol Med, 17: 486-494, 2011.
    119. Wang YC, Tang FY, Chen SY, Chen YM*, Chiang EP. Glycine-N methyltransferase expression in HepG2 cells is involved in methyl group homeostasis by regulating transmethylation kinetics and DNA methylation. J Nutr. 141: 777-782, 2011.
    120. Fan AP, Kosik RO, Su TP, Lee FY, Hou MC, Chen YM, Chen CH, Lee CH. Factors Associated with Suicidal Ideation in Taiwanese Medical Students.Medical Teacher 33: 256-257, 2011.
    121. Chen M, Ho CW, Huang YC, Wu KY, WuMT, Jeng HA, Chen CJ, Shih TS, Lai CH, Pan CH*, Chen YM*.Glycine N-methyltransferase affects urinary 1-hydroxypyrene and 8-hydroxy-2-deoxyguanosine levels after PAH exposure. J. Occup. Env. Med. 53; 812-819, 2011.
    122. Peng EY, Yeh CY, Cheng SH, MoriskyDE, Lan YC, Chen YM Lyu SY*, MalowRM.A case-control study of HIV infection among incarcerated female drug users: impact of sharing needles and having drug-using sexual partners. J Formos Med Assoc. 110; 446-453, 2011.
    123. Lee YM, Chen YJ,Lee CM, Kuo LH, Wong WW and Chen YM*. Detection of hepatitis C virus subtypes 6a, 6n, 6w and mixed infections using a modified multiplex RT-PCR protocol. J Formos Med Assoc 110: 762-767, 2011.
    124. Wang SF, Chen KH, Chen M, Lee WY, Chen YJ, Huang JC, Chen YM*. Human-Leukocyte-Antigen Class I Cw 1502 and Class II DR 0301 Genotypes are Associated with Resistance to Severe Acute Respiratory Syndrome (SARS) Infection. Viral Immuno 24: 421-426, 2011. (Epub ahead of print, Sep 29,2011)
    125. Chen YJ, Lin YT, Chen M, Huang SW, Lai SF, Wong WW, Tsai HC, Lin YH, Liu HF, Lyu SY, Chen YM*. Risk factor for HIV-1 seroconversion among Taiwanese men who have sex with men attending gay saunas. BMC Infect. Dis. 11: 334-339, 2011.
    126. Lyu SY, Su LW, Chen YM*.  Effects of education on harm-reduction programmes. Lancet 379: e28-e30, 2012 [Epub ahead of print August 17, 2011].
    127. Yen CH, Lu YC, Li CH, Lee CM, Chen CY, Cheng MY, Huang SF, Chen KF, Cheng AL, Liao LY, Wu Lee YH, Chen YM*. Functional Characterization of GNMT and its interacting protein-DEPTOR in hepatocellular carcinoma. Mol. Med. 18: 286-96. 2012 (2011 Dec 1. Epub ahead of print).
    128. Poh-Lian Lim, Jialun Zhou, Rossana A Ditangco, Matthew G Law, Thira Sirisanthana, Nagalingeswaran Kumarasamy, Chen YM, Praphan Phanuphak, Christopher KC Lee, Vonthanak Saphonn, Shinichi Oka, Fulie Zhang, Jun Y Choi, Sanjay Pujari, Adeeba Kamarulzaman, Patrick CK Li, Tuti P Merati, Evy Yunihastuti, Liesl Messerschmidt and Somnuek Sungkanuparph. Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database. J Int AIDS Soc, 15: 1-9, 2012.
    129. Liao YJ, Chen TL, Lee TS, Wang CK, Liao LY,Wang HA,Liu RS, Huang SFand Chen YM*. Glycine N-methyltransferase deficiency affects Niemann-Pick Type C2 protein stability and regulates hepatic cholesterol homeostasis. Mol. Med., 18: 412-422, 2012.
    130. Yang CP, Wang HA, Hsu CL,  Fan Angela, Tsai TH,Chen CJ, Hong CJ, Chen YM*. Characterization of the neuropsychological phenotype of glycine N-methyltransferase -/- mice and evaluation of its responses to clozapine and sarcosine treatments. Eur. Neurpsychopharmacol.
    131. Chen YJ, Lee CM,Chen M, Chuang SY, Liu HF, Wong WW, Lin YH, Tsai HC, Chen YM*. Molecular Epidemiology of HIV-1 Infection in Taiwan from 2005 to 2008: Further spread of CRF07_BC and emergence of CRF07_BC/subtype B dual infection. J. Acquir. Immune. Defic. Syndr. (JAIDS), 59: 438-446, 2012.
    132. Chen CY, Ching LC, Liao YJ, Yu YB, Tsou CY, Shyue SK, Chen YM*, Lee TS* Deficiency of Glycine N-methyltransferase Aggravates Atherosclerosis in Apolipoprotein E-null Mice. Mol Med 18:744-52; 2012 [Epub ahead of print March 8, 2012].
    133. Zhou J, Tanuma J, Chaiwarith R, Lee CK,, Matthew G Law MG, Kumarasamy N, Phanuphak P, Chen YM, Kiertiburanakul S, Zhang F, Vonthanak S, Ditangco R, Pujari SN, Choi JY, Merati T, Yunihastuti E, Li P, Kamarul A. Loss to follow-up in HIV-infected patients from Asia-Pacific region: results from TAHOD. AIDS Res Treat, AIDS Res Treat. ;2012:375217. doi: 10.1155/2012/375217. Epub 2012 Feb 22.
    134. Oyomopito RA, Li PCK, Sungkanuparph S, Phanuphak P, Tee KK, Sirisanthana T, Kantipong P, Oka S, Lee CKC, Kamarulzaman A, Choi JY, Sohn AH, Law M, Chen YM. Evaluating immunologic response and clinical deterioration in treatment-naïve patients initiating first-line therapies infected with HIV‑1 CRF01_AE and subtype B. JAIDS, in press, 2012. Nov 7. [Epub ahead of print]
    135. Meda ZC, Lin YT, Sombie I, Mare D, Morisky D, Chen YM.* Medical Adherence predictors among patients with tuberculosis or human immunodeficiency virus infection in Burkina Faso. J Microbio Immun Inf, In press, 2012.
    136. Luong HM, Wang SF, Trao VT, Lin YT, Chen M, Huang JC, Cam PD, Chen YM.* Retrospective survey of avian influenza H5N1 infection in Northern Vietnam by using a combinational serologic assay. Health,
    137. Yen JH, Lin YT, Chen HL, Chen YM*. The Multi-functional roles of GNMT in toxicology and cancer. Toxicol Appl Pharmacol, 266:67-75, 2013.
    138. Lee YM, Lin YT, Chen YM.* Seroepidemiology of HHV-8 and Parvovirus B-19 in HIV-infected persons in Taiwan. J Microbio Immuno Infec, in press, 2013.
    139. Liao YJ, Yen CH, Chen YM.*. Phosphorylated forms of GNMT in mouse liver, J Proteomics, 2013 Jan 20. pii: S1874-3919(13),2013.01.007 [Epub ahead of print]
    140. Tran DT, Kosik RO, MandellGA, Chen YM, Su TP, Chiu AW, Fan AP. Tobacco control in Vietnam. Public Health, 127: 109-118, 2013.
    141. Lin YL, Chen YM*. The Serologic Decoy Receptor 3 (DcR3) Levels are Associated with Slower Disease Progression in HIV-1/AIDS Patients. J Formos Med Assoc, in press, 2013.
    142. Lee CM, Yen CH, Tzeng TY, Huang YZ, Chou KH, Chang TJ, Chen YM.* Androgen response element of the glycine N-methyltransferase gene is located in the coding region of its first exon. Biosci Rep 2013; 17: 3333(5). pii: e00070. doi: 10.1042/BSR20130030.
    143. Meda ZC, Lin YT, Sombie I, Sanon OWC, Mare D, Morisky D, Chen YM*. Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso. AIDS Res Human Retrovir, 29: 1045-1055, 2013.
    144. Lin IY, Yen CH, Liao YJ, Lin SE, Ma HP, Chan YJ, Chen YM*.
    145. Wang YC, Lin WL, Lin YJ, Tang FY, Chen YM, Chiang EP. A novel role of the tumor suppressor GNMT in cellular defense against DNA damage. Int J Cancer 2013 Aug 7. doi: 10.1002/ijc.28420. [Epub ahead of print].
    146. Liao YJ, Yen CH, Lin YT, Wang CK, Huang SF, Chen KH, Yang CP, Chen TL, Chen YM*. Characterization of Niemann-Pick Type C2 (NPC2) protein expression in multiple cancers using a novel NPC2 monoclonal antibody. PLoS ONE, 8 (10):e77586.
    147. Wu WH, Kuo TC, Lin YT, Huang SW, Liu HF, Wang J, Chen YM.*Molecular Epidemiology of Enterovirus 71 Infection in the Central Region of Taiwan from 2002 to 2012. PLoS ONE, 2013 Dec 31;8(12):e83711. doi: 10.1371/journal.pone.0083711. eCollection 2013.
    148. Lee CM, Yen CH, Tzeng TY, Huang YZ, Chou KH, Chang TJ, Chen YM.* Androgen response element of the glycine N-methyltransferase gene is located in the coding region of its first exon. Biosci Rep 2013; 17: 3333(5). pii: e00070. doi: 10.1042/BSR20130030.
    149. Chen M, Huang YL, Huang YC, Shui IM, Giovannucci E, Chen YC, Chen YM.
    150. Méda ZC; Lin YT; Sombié I; Maré D; Morisky DE; Chen YM.* Medication-adherence Predictors among Patients with Tuberculosis or Human Immunodeficiency Virus Infection in Burkina Faso. Journal of Microbiology, Immunology and Infection. 247: 222-232, 2014.
    151. Chen M, Jen I, Chen YH, Sharp G, Chen YM*. Cancer Incidence and Survival in a Nationwide HIV/AIDS Patient Cohort in Taiwan in 1998-2009. JAIDS, 64: 463-,472, 2014.
    152. Chou WY, Zhao JF, Chen YM, Lee KI, Su KH, Shyue SK, Lee TS. Role of glycine N-methyltransferase in experimental ulcerative colitis. J Gastro Hepatol, 29: 494-501, 2014.
      1. Jeng KS, Hu CP, Lo SJ, Chen YM, Su TS, Ting LP, Chou C H, Hana SH, Salfeld J, Pfaff E, Schaller H, Chang C. Production of hepatitis B virus by transfection of cloned hepatitis B virus DNA in a hepatoma cell line.  In: Viral Hepatitis and Liver Disease.  Alan R. Liss, Inc., 1988, pp. 355-359.
        1. Chen YM, Essex M.  Antibody responses to different regions of HTLV-1 gp61 in asymptomatic carriers, ATL patients and individuals with TSP.  In: Human Retrovirology: HTLV (W. Blattner, Ed.).  Raven Press, 1990, pp. 447-460.
        2. Chen YM, Essex M. Immunogenicity of human retrovirus-specific proteins. In: Gene Regulation and AIDS (T. S. Papas, Ed.).  Gulf Publishing Co., Houston, 1990, pp. 239-245.
        3. Chen YM, Sankale J-L. Chapter 4: Other human retroviruses. In Essex, M., Mboup, S., Kanki, P. J. and Kalengayi, M. R. (eds.): AIDS in Africa. Raven Press, New York, 1994, pp. 67-95.
    153. Horng C-B, Chen YM, Chang PL. Vaccine development in Taiwan. Proceedings of the Asia-Pacific Conference on Health Care in the 21st Century. Taipei, Taiwan. 1994.
    154. Chen YJ, Lee MD, Liu MH, Chen PH, Chen YM. The study of p16 (MTS1) gene expression in gastric cancer cell lines and uncultured gastric cancers. In Nishi M, Sugano H, and Takahashi T, (eds): Proceedings of the 1st International Gastric Cancer Congress, Monduzzi Editore, Italy, pp. 713-717, 1995
      1. Chen YM. Preventive Medicine. (Writer and Editor). Chinese Society of Preventive Medicine Press, 1996. 
      2. Chen YM, Lin R-H, Fu C-Y, Lin R-Y, Syu W-J. Decreasing levels of anti-Nef antibody correlate with increasing viral loads in HIV-1 infected people with differing clinical status. Proceedings of the 12th World AIDS Conference. Monduzzi Editore, Italy, volumn 2, pp. 627-634, 1998.
      3. Chen YM, Lee C-M. Molecular epidemiology of HIV-1 inTaiwan: heterosexual males with HIV-1 E had significantly higher rate of transmission than those with HIV-1 B. Proceedings of the 12th World AIDS Conference. Monduzzi Editore, Italy, volumn 3, pp. 29-35, 1998.
      4. Chen YM.  HIV/AIDS in Taiwan. In AIDS in Asia, Lu YC and Essex M (ed.), p.p. 135-144, Kluwer Academic Publisher. 2004.
    155. Huang YC, Shih YP, Li CC, Liao LY, Chen YM. Characterization of genetic polymorphism of glycine N-methyltransferase gene in hepatocellular carcinoma. In Hormonal Carcinogenesis IV, Li JJ, Li SA and Llombart-Bosch A (ed.), p.p. 293-299, 2004.
    156. Hsieh JL, Huang CY, Sun CT and Chen YM. Using the CAMIM Small-World Epidemic Model to Analyze Public Health Policies. In Proceedings of Western Multiconference, New Orleans, LA, pp. 63-69, 2005.
    157. Sumodhee C., Hsieh J.L., Sun C.T., Huang C.Y., and Chen Y.M. Impact of Social Behaviors on HIV Epidemic: A Computer Simulation View. In Proceedings of IEEE Computational Intelligence for Modelling Control and Automation (CIMCA’05), Vienna, Austria, pp. 130-134. (IEEE), 2005.
      1. Chen YM. The 2003 SARS outbreaks in Taiwan. Growing infections in Asia. Lu YC, Essex M and Robert B (eds.), Springer, pp. 119-134, 2008.
    158. Wang SF and Chen YM. Chapter 5, The Interactions between Avian H5N1 Influenza Virus and Dendritic Cell-Specific ICAM-3 Grabbing Non-Integrin (DC-SIGN). Global View at Fight against Influenza. (Nova Science Publishers), In press, 2009.
    159. Wang SF and Chen YM. The Emergence of HIV-1 Circulating Recombinant Form 07_BC Strains in Taiwan. Emerging Infectious Diseases: Global Trends, Surveillance and Eradication. (Nova Science Publishers). In press, 2009.
    160. Li P and Chen YM. Introduction. Is it HIV? A handbook for health care providers. Ed. Menon A., Kamarulzaman A. Australian Society for HIV Medicine. P.p. 6-8, 2009.
    161. [愛滋世界]。陳宜民。翻譯自Jonathann Mann AIDS in the World. 2nd edtion. 1999. (全書共632頁)。預防醫學出版社出版。
    162. [預防醫學]。陳宜民。巨流出版社。2003
    163. [愛之新生]。陳宜民主編。第六版。
    164. [第三章:愛滋病病毒之分子流行病學]藍郁青,陳宜民。[愛滋病學]第二版。健康文化事業股份有限公司,
    165. [第二十六章:愛滋病疫苗研發現況及未來展望]。林郁婷,陳宜民。[愛滋病學]第二版。健康文化事業股份有限公司。
    166. [諾貝爾生醫獎人類乳突病毒與愛滋病病毒]。陳宜民。[科學月刊]2008, 12月號。468期,924-931頁。
    167. [第十章,愛滋病毒的基因變異]。藍郁青,楊依蓁,陳宜民。[傳染病學]。中國醫藥大學出版。2011, 8月。147-151頁。
    168. Chen YM, Gomez-Lucia, E., Okayama, A. et al. The antiobdy profile of early HTLV-1 infection. The Third International HTLV meeting, Hawaii. April 1990.
    169. Chen YM, Wiktor SZ, Shaw GM. et al. Type-specific antigens for serological discrimination of HTLV-I and HTLV-II infection. The fourth International HTLV meeting. Jamaica, Feb. 1991.
    170. Chen YM,Lin R-H,Lee C-M, and SyuW-J.Evaluation of the anti-HIV-1-Gag and Nef Antibody Reactivities as Clinical Markers for AIDS Disease Progression and Response to Triple Therapy. (Invited speaker). 3rd International Symposium on Clinical Virology, Tai-Nan, Taiwan, march 1999.
    171. Chen YM, Lee C-M, Lin J-R V, Chen L-Y, Lin C-H, Hsieh L-L, Yang S-C, Liu T-Y, Wong F-H. Glycine-N-methyltransferase-gene expression and the hepatocarcinogenesis. (Invited speaker) 2nd International Symposium on liver Cirrhosis and Liver Cancer. Kyoto, Japan, June 1999.
    172. Chen YM. Decreasing levels of anti-Nef antibody correlate with increasing viral loads and AIDS disease progression. Invited speaker at the Symposium on Recent Advancement of HIV Therapy. Taipei, Feb. 2000.
    173. Chen YM. The AIDS Epidemics and the Human Right Issues in Taiwan. Invited speaker at the Satellite Symposium on “HIV/AIDS in Chinese Community-Threats and Opportunities in the New Millennium” XIII International AIDS Conference. July 2000.
    174. Chen YM. GNMT and liver cancer. Invited speaker at the Laboratory of Population Genetics, National Cancer Institute, NIH, Bethesda, Feb., 2000.
    175. Chen YM. Virologic markers associated with AIDS disease progression. Invited speaker at the National Annual AIDS Meeting of Philippine. Manila, Oct. 2000.
    176. Chen YM. Molecular Epidemiology of HIV-1 Subtypes: Methodology and Application. Invited speaker at the National Annual AIDS Meeting of Philippine. Manila, Oct. 2000.
    177. Chen YM, Chung CL, Wu SI, Hsu H. A Survey on the HIV-1, syphilis and sexual behavior among men attending gay saunas in TaipeiCity. 2001 Hong Kong AIDS Meeting. August 2001.
    178. Chen YM. Molecular Epidemiology and temporal trends of HIV-1 subtypes in Taiwan and a survey on the HIV-1, syphilis and sexual behavior among men attending gay saunas in TaipeiCity. International AIDS Conference in Taiwan. (Invited speaker) March 2001.
    179. Chen YM. Molecular epidemiology of HIV-1 and surveys of STDs in gay saunas in Taiwan. The 15th Annual Meeting of Japanese AIDS Society, Nov 2001.
    180. Chen YM. Clinical Implications of anti-Nef and anti-Vpu antibodies in patients on HAART. The 15th Annual Meeting of Japanese AIDS Society, Nov 2001.
    181. Chen YM. Delineation of the mechanism of glycine N-methyltransferase gene control in hepatocellular carcinoma. The 4th France-Taiwan Conference on Virus and Cancer. Kenting, Taiwan, Nov. 2001.
    182. Chen YM. SARS Prevention in Taiwan. International Conference on SARS Control. Beijing. April 2003.
    183. Chen YM. Molecular epidemiology of HIV-1 subtypes and SARS coronavirus infection in Taiwan. UCLASchool of Public Health. August 11, 2003.
    184. Chen YM, Liang CY, Shih YP, et al. Establishment of a confirmatory test for SARS infection. International Conference on SARS. Beijing. August 2003.
    185. Chen YM. The establishment and operation of the PWA’s Rights’ Advocacy Association in Taiwan. International Seminars on HIV/AIDS: Social Behavior, Stigma and Discrimination. Beijing, China, July 2004.
    186. Chen YM. Molecular epidemiology and serological diagnosis of SARS infection in Taiwan. Invited speaker at the TartuUniversity, Tartu, Estonia, April 6, 2005.
    187. Chen YM. Evolving HIV epidemic in Taiwan: context, current situation and response. Invited speaker at the Estonia National Medical days. Tallinnas, Estonia, April 7-8, 2005.
    188. Chen YM. Molecular epidemiology, phylogenetic and genomic analysis of HIV-1 circulating recombinant form 07_BC among injecting drug users in Taiwan. First Taiwan-Netherlands Workshop on Pathogenomics. Amsterdam, Netherlands, April 9-11, 2006.
    189. Chen YM. Trade Related Infections, Traveling and the Spread of Emerging Infectious Diseases. 2006 International Workshop on “WTO Agreement and Public Health”. May 3-4. Taipei, Taiwan.
    190. Chen YM. Aim for Excellence: The experiences of international collaboration at Yang-MingUniversity. UK-Taiwan Higher Education Conference, Taipei, Taiwan. November 5, 2007.
    191. Chen YM. Molecular epidemiology of HIV-1 and HCV infection in Taiwan. 2007 Annual Meeting of Taiwan Society of Biochemistry and Molecular Biology. Oct. 19-20, 2007.
    192. Chen YM. Molecular epidemiology of HIV-1 and HCV infection in Taiwan. International Conference on Control of Tropical Infectious Diseases and Cancer in Taiwan and South Pacific. Nov. 10-11, 2007.
    193. Chen YM. Review the history: epidemiology of SARS coronavirus infection in Taiwan. 2007 International Symposium on Humanity Care in the Post-SARS Era. Nov. 21-22, 2007.
    194. Chen YM. Molecular epidemiology of HIV and HCV infection in Taiwan. 1st UK-Taiwan International Networking for Young Scientists Symposium on Infection and Immunity. Taipei, March, 2008.
    195. Chen YM. Characterization of a GNMT-/- mouse model for hepatocellular carcinoma. Joint Symposium between National Yang-Ming University , Taiwan and University of California San Diego. San Diego, April 2008.
    196. Chen YM. Proteomic and epigenomic analyses of a GNMT-/- mouse model. Taiwan Proteomics Society Eastern International Conference, TzuChiMedicalCenter, June, 2008.
    197. Chen YM. How we promote human right protection issues for HIV-1/AIDS patients in Taiwan. Presentation in Observatory of HIV and sexuality,in the Facultés Universitaires Saint Louis, au Salon des Professeurs, rue du Marais 109, 5ème étage, Belgium, 2008.
    198. Chen YM. HIV-1 infection in Asia: How Harm Reduction Program Turn the Tide of HIV-1 Epidemic in Taiwan.  Presentation in Chu St. Pierre Forum. Department of Infectious Diseases, Chu St. Pierre, The European AIDS Clinical Society (EACS). Belgium. September 9, 2008.
    199. Chen YM. Emerging Infectious Disease. 2008 Global Forum for Health Leaders. November 3-4, Taipei, Taiwan.
    200. Chen YM. Molecular epidemiology of HIV-1 infection and evaluation of the harm reduction program in Taiwan. Biostatistics Day Symposium. November 26, 2008, Taichung, Taiwan.
    201. Chen YM. Evaluation of the harm reduction program in Taiwan. 2008 Healthy City Symposium in Taipei. December 6-7, 2008. Taipei, Taiwan.
    202. Chen YM. Epidemiology of HIV-1 infection and evaluation of harm reduction program in Taiwan. The Asian Administrative Meeting on HIV/AIDS, Kunming, Yunnan, China. Organized by Ministry of Health, Labor and Welfare of Japan, March 18-19, 2009.
    203. Chen YM. Molecular epidemiology of HCV infection among HIV-1-infected IDU in Taiwan. U.S.Japan Joint AIDS-Hepatitis Meeting. Portland, Oregon, September 19-21, 2009.
    204. Chen YM. Hepatitis B and C virus co-infection in the TREAT Asia HIV Observational Database. U.S.Japan Joint AIDS-Hepatitis Meeting. Portland, Oregon, September 19-21, 2009.
    205. Chen YM. Molecular epidemiology of HCV infection among HIV-1-infected IDU in Taiwan: identification of a new subtype 6w. The 2ndTaiwan NSC-Japan JST Joint Meeting. Kyoto, Japan, November 16-17, 2009.
    206. Chen YM. Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma. YamaguchiUniversity, November 20, 2009.
    207. Chen YM. HIV-1 inTaiwan: Effects of Education on Harm-Reduction Programs and Challenges of Preventive Programs among MSM. AIDS Research Institute, UCSF, June 28, 2011.
    208. Chen YM. Characterization of a GNMT-gene knockout mouse model for neurodegenerative diseases. The Neurodegenerative Disease Research Laboratory, UCSF, June 27, 2011.
    209. Chen YM. From AIDS to Liver Cancer. Chang-GungMedicalUniversity, Tao-Yuan Prefecture, Taiwan, October 21, 2011.
    210. Chen YM. Molecular epidemiology of HIV infection in Taiwan and evaluation of the harm reduction program. Yang-MingUniversityHospital, I-LanPrefecture, October 26, 2011.
    211. Chen YM. 海峽兩岸生物醫藥合作趨勢和前景分析. 2011首屆生物醫藥創新投資論壇. 北京。2011-11-8.
    212. Chen YM. Molecular epidemiology of HIV-1 CRF07_BC and HCV 6w infection in Taiwan. ISBT International Society of Blood Transfusion meeting. Novatis Satellite symposium. Taipei. November, 2011.
    213. Chen YM. Multi-fuction of GNMT and it’s association with liver cancer. Taiwan Liver Cancer Association Annual Meeting-Promising in HCC diagnosis and treatment. Nov. 24, 2012.
    214. Huang SW, Lin YT, Hung CP, Chen YH, Yang JY, Lin SR, Chen YM.Molecular EpidemiologyInternational Conference on Pre-exposure Prophylaxis, Tainan, March, 2013.
    215. Chen YM. The role of GNMT plays in the liver tumorigenesis and its usefulness in the targeted therapy for hepatocellular carcinoma. Annual United Science Meeting, April, 2013.
    216. Chen YM, Lee TH, Samuel KP et al. Antibody response to different regions of HTLV-1 gp61 in asymptomatic carriers. ATL patients and individuals with TSP. The Second International HTLV Meeting, Trinidad. Feb. 1989.
    217. Chen YM, Lee TH, Samuel KP et al. Antibody reactivity to different regions of HTLV-1 gp61 in infected people. RNA tumor virus meeting. Cold Spring Harbor, USA.  May 1989.
    218. Chen YM, Lee TH, Samuel KP et al. Antibody reactivity to different regions of HTLV-1 gp61 in infected people Annual meeting of American Society of Microbiology, West Ontario, Canada. Sep. 1989.
    219. Chen YM, Okayama A, Lee TH et al. Antibody reactivity of different high-risk groups to HTLV-1 ENV and Tax recombinant protein. Annual Meeting of Lab of Tumor Immunology, NIH, MD, USA.  Sep. 1989.
    220. Chen YM, Okayama A, Lee TH et al. Sexual transmission of HTLV-1 associated with the presence of the anti-Tax antibody. The Third International HTLV meeting, Hawaii. April 1990.
    221. Chen YM, Lee TH, Wiktor SZ et al. Mapping the type-specific epitopes on the HTLV-1 and -II envelope glycoprotein. RNA tumor virus meeting. Cold Spring Harbor, USA. May 1990.
    222. Gomez-Lucia E, Chen YM, Yu Q-C, Essex M. Experimental infeciton of monocytes by HTLV. RNA tumor virus meeting.  Cold Spring Harbor, USA. May 1990.
    223. Chen YM, Lee TH, Essex M. HTLV-1 Envelope glycoprotein:the biological and epidemiological significance. International Human Retro virology: HIV & HTLV Conference, Taipei, R.O.C. Sep. 1990.
    224. Chen YM, Samuel KP, Blattner W et al. Mapping the type-specific regions on HTLV-I and HTLV-II envelope glycoprotein. International AIDS Conference. Florance Italy, June 1991.
    225. Chen YM, Zhang X-g, Dahl C. et al. Delineation of type-specific regions on HTLV envelope glycoproteins and its serological application. The Sixth International AIDS in Africa Conference. Dakar, Senegal. Dec. 1991.
    226. Chen YM. Delineation of type-specific regions on HTLV envelope glycoproteins by Recombinant protein-Western blot assay and ADCC. The NIH HTLV vaccine-perspective workshop. Bethesda, USA. Jan. 1992.
    227. Chen YM. Delineation of the HTLV type-specific regions by recombinant Env proteins and ADCC assays. The Second International Taipei AIDS Conference. Taipei, ROC. May.
    228. Chen YM,Kanki PJ, Jang YJ, et al. Isolation of simian T-lymphotropic virus type II (STLV-II) from new world monkeys. The IXth International Conference of AIDS, Berlin. 1993.
    229. Jen I, Lan JF, Lin HT,Chen YM. A modified aids risk reduction model (ARRM) for female sex workers in Taiwan. The IXth International Conference of AIDS, Berlin, 1993.
    230. Chen YM,Kanki PJ, Jang YJ, et al. Isolation of simian T-lymphotropic virus type II (STLV-II) from new world monkeys. Retroviruses meeting. Cold Spring Harbor, USA. May 1993.
    231. Lee MS, Chen YM, Chen SH, King CC, Wu YC, Horng CB, Chou P. Evaluation of two hepatitis B virus immunization programs in an isolated islet-Kinmen, Fukien, Republic of China, 1993. The third International Conference on Viral Disease, Kunming, China, 1993.
    232. Chen YM, Sheu T-T, Lee CM, Jang Y-J.The V3 region of HIV-1 isolates prevalent in Taiwan contains a unique signature and E subtype sequence. The Xth International Conference on AIDS, Yokohama, Japan, August 1994.
    233. Jen I, Chen YM. The seropositive rates of HIV-1, HTLV-I, syphilis, and HBV infections among illegal sex workers and servants in Taipei city. The Third Taipei International AIDS Conference. Taiwan, ROC. August 1994.
    234. Chin W-Y, Chang L-Y, Chou P, Chen YM. An evaluation of the impact of an AIDS education program offered to beauty parlor personnel in the Song-San District of Taipei, Taiwan. The Third Taipei International AIDS Conference, Taiwan, ROC. August 1994.
    235. Yao C, Kuo H-S, Chen YM. Economic analyses of the blood screening programs for HIV-1 and HIV-2 in the blood donation centers in Taiwan. The Third Taipei International AIDS Conference. Taiwan, ROC. August 1994.
    236. Chen YM, Lin H-C, Whang-Peng J. Molecular epidemiology of human immunodeficiency virus infection in Taiwan. First APSN International Symposium and Workshop, Singapore, August 1994.
    237. Chen YJ, Jang YJ, Lee MD, Liu MH, Chen PH, Whang-Peng J, Chen YM. A novel mitochondrial ADP/ATP translocase gene identified from human gastric carcinoma tissue by mRNA differential display. The World Congress of Gastroenterology. Los Angeles, CA, USA, October 1994.
    238. Chen YM, Lin H-C, Whang-Peng J. Molecular epidemiology and phylogenetic tree analysis of HIV-1 infection in Taiwan. 7th Asian-Pacific Congress of Clinical Biochemistry, Bangkok, Thailand, September 1995.
    239. Chen YJ, Lee MD, Liu MH, Chen PH, Chen YM. The study of p16 (MTS1) gene expression in gastric cancer cell lines and uncultured gastric cancers. The Society of Surgical Oncology's 48th Annual Cancer Symposium, Boston, USA. March 1995.
    240. Chen YM. Differential diagnosis of HIV-1 vs. HIV-2, HTLV-I vs. HTLV-II and HIV-1 subtyping. International Symposium on Diagnosis of Viral and Chlamydial Infection. Tainan, ROC. March 1996.
    241. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I regulatory gene products (Tof, Rev and Tax) in HTLV-I infected people with different clinical status. Retroviruses meeting, Cold Spring Harbor, USA.  May 1996.
    242. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I regulatory gene products (Tof, Rev and Tax) in HTLV-I infected people with different clinical status. Annual meeting for Chinese Society of Oncology, Taipei, Taiwan. May 1996.
    243. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I regulatory gene products (Tof, Rev and Tax) in HTLV-I infected people with different clinical status. The XIth International Conference on AIDS, Vancuver, Canada. August 1996.
    244. Chen YM. Current situation of HIV-1 infection in Taiwan, a community report. Global response to HIV/AIDS from Chinese communities. An official satellite symposium of the XIth International Conference on AIDS, Vancouver, Canada, August 1996.
    245. Chen YM, Chen S-H, Fu C-Y, Chen J-Y, and Osame M. Antibody reactivities to p53 and HTLV-I regulatory proteins- tax, rex and tof in HTLV-I infected people. The 4th International AIDS Conference, Taipei, Taiwan. December 1996.
    246. Yao C, Wang W-W, Chung Y-M, Su Y-L, Liu C-Y, and Chen YM. Transfusion-acquired AIDS In Taiwan. The 4th International AIDS Conference, Taipei, Taiwan. December 1996.
    247. Chen YM, Ting S-T, Liu W-T, Pan W-H, Chou P. Community-based molecular epidemiology of human T-cell leukemia virus type I infection in Kin-hu, Kinmen and three townships in Taiwan. The 4th International AIDS Conference, Taipei, ROC. December 1996.
    248. Jen I, Chang L-Y, Lin R-Y, Chen YM. Survey of knowledge, attitudes and practices concerning AIDS among female sex workers in Taipei, Taiwan. The 4th International AIDS Conference, Taipei, ROC. December 1996.
    249. Chen YM, Lin C-C, Lin R-Y. Surveys of HIV-1, HTLV-I and other sexually transmitted infections (STI) among female sex workers in Taipei, Taiwan. The 4th International AIDS Conference, Taipei, ROC. December 1996.
    250. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I regulatory gene products (Tof, Rev and Tax) in HTLV-I infected people with different clinical status. Retroviruses meeting, Cold Spring Harbor, USA.  May 1996.
    251. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I regulatory gene products (Tof, Rev and Tax) in HTLV-I infected people with different clinical status. Annual meeting for Chinese Society of Oncology, Taipei, Taiwan. May 1996.
    252. Shiu J-YA, Tzeng S-J, Chen Y-J, Lui W-Y, Chen YM. cDNA cloning and sequencing of human glycine N-methyl transferase whose expression is diminished in human hepatocellular carcinoma. Annual meeting of Chinese Society of Oncology, Taiepi, Taiwan. May 1996. (*The first award of the poster competition).
    253. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I regulatory gene products (Tof, Rev and Tax) in HTLV-I infected people with different clinical status. The XIth International Conference on AIDS, Vancuver, Canada. August 1996.
    254. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I infected people with differing clinical status. VIII International Conference on Human Retrovirology: HTLV. Rio de Janeiro, Brazil. June 1997.
    255. Chen YM, Ting S-T, Lee C-M, Pan W-H, Saitou N, Chou P. Population-based molecular epidemiology of human T-cell leukemia virus type I in Taiwan and Kinmen islands. VIII International Conference on Human Retrovirology: HTLV. Rio de Janeiro, Brazil. June 1997.
    256. Yu PS, Jen I, Lin C-C, Lin R-Y, Chen YM. Surveys of HIV-1 HTLV-I and other sexually transmitted diseases among female sex workers in Taipei city and prefectures, Taiwan from 1993 to 1996. 4th International Congress of the AIDS in the Asia and Pacific. Manila, Philippine. Oct. 1997.
    257. Chen YM. Current situation of HIV-1 infection in Taiwan, a community report. Global response to HIV/AIDS from Chinese communities. 4th International Congress of the AIDS in the Asia and Pacific. Manila, Philippine. Oct. 1997.
    258. Chen YM, Shiu J-Y, Tzeng SJ, Lui W-Y. Characterization of glycine N-methyltransferase gene expression in human hepatocellular carcinoma. Regulation of Liver Gene Expression in Health & Disease. ColdSpringHarborLaboratory, New York, USA. April 1997.
    259. Chen Y-J, Shih L-S, Chang J-G, Whang-Peng J, Chen YM. Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma. The 2nd Annual Taiwan Joint Cancer Conference. Taiepi, ROC. May 1997.
    260. Chen YM, Chen S-H, Osame M, Chen J-Y. Antibody reactivities to tumor suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I infected people with differing clinical status. VIII International Conference on Human Retrovirology: HTLV. Rio de Janeiro, Brazil. June 1997.
    261. Chen YM. Comparison of a modified HIV-1 Monitor test and a branched DNA assay for the quantitation of HIV-1 RNA in triple therapy. 1998 Bangkok Symposium on HIV Medicine, Bangkok, Thailand. January 1998.
    262. Chen YM. Comparison of a modified HIV-1 Monitor test and a branched DNA assay for the quantitation of HIV-1 RNA in triple therapy. 1998 Taipei Symposium on Current Treatment and Vaccine Development for HIV Infection. Taipei, ROC. April 1998.
    263. Chen YM, Lin R-H, Fu C-Y, Lin R-Y, Syu W-J. Decreasing levels of anti-Nef antibody correlate with increasing viral loads in HIV-1 infected people with differing clinical status. The 12th World AIDS Conference. Geneva. June 1998.
    264. Chen YM, Lee C-M, Lin R-Y. Molecular Epidemiology of HIV-1 inTaiwan: Heterosexual Males with HIV-1 E Had Significantly Higher Rate of Transmission than Those with HIV-1 B. The 12th World AIDS Conference. Geneva. June 1998.
    265. Chen YM. The strategies of advocating AIDS prevention and treatment in Taiwan. Global response to HIV/AIDS from Chinese communities. An official satellite symposium of the 12th World AIDS Conference. Geneva. June 1998.
    266. Chen YM and Lee C-M. Molecular epidemiology of HIV-1 infection in Taiwan. Annual Spring Meeting of the Taiwan Medical Assocation. May 1998.
    267. Chen YM. The present situation of HIV epidemics and treatment in Taiwan. International Conference on the Treatment of AIDS, Beijing, Oct. 1998.
    268. Chen YM. Decreasing levels of anti-Nef antibody correlate with increasing HIV-1 viral loads and AIDS disease progression. The 7th Annual Meeting of Chinese Society of Immunology, Taipei, Nov. 1998.
    269. Lee C-M, Lin R-H, Syu W-J, Chen S-C, Chen YM. A Study of the Anti-Nef Antibody as a Serological Marker for AIDS Disease Progression. The 30th Annual Meeting of Chinese Society of Microbiology, Taipei, Nov. 1998.
    270. Hsu Y, Chen Y-J, Chen S-T, Chen YM. Characterization of Rb and CDKN2 (p16INK4A/MTS1) tumore suppressor genes in human esophageal carcinoma. The 3rd Taiwan Joint Cancer Conference. Taipei, April 1998. (*Among 59 posters participated in the competition, it has won the top 8 award).Lin J-R V, Lee C-M, Hsieh
    271. L-L, Liu T-Y, Chen YM. The Interaction of Glycine N-methyltransferase and Carcinogens- (Benzo[a]pyrene and Aflatoxin B1) in Liver Cancer Cells. The 30th Annual Meeting of Chinese Society of Microbiology, Taipei, Nov. 1998.
    272. Chen YM. Current situation of HIV infection and prevention strategy in gay community in Taiwan. (Invited speaker) UNAIDS and ASAP Workshop on MSM. Singapore, Feb. 1999.
    273. Chen YM, Lee C-M, Lin R-H, Syu W-J, Chen S-C. Antibody Responses to HIV-1 Nef and Gag Proteins Correlate with Viral Loads and AIDS Disease Progression. 5th International AIDS Conference in Taipei. Feb. 1999.
    274. Chen YM, Lee C-M, Lin R-Y, Chen S-C. Molecular Epidemiology and Trends of HIV Subtypes in Taiwan. 5th International AIDS Conference in Taipei. Feb. 1999.
    275. Chen YM, Huang K-L, Chen S-C, Chang H-J. Molecular epidemiology of HIV-1 Infection in Taiwan. Fifth International Congress on AIDS in Asia and Pacific. Kuala Lumpur. (Oral) Oct. 1999.
    276. Chen YM. The present situation of human right issues of HIV/AIDS patients in Taiwan. (Invited speaker). Fifth International Congress on AIDS in Asia and Pacific. Kuala Lumpur. Oct. 1999.
    277. Chen YM, Lin J-R V, Lee C-M, Lin C-H, Hsieh L-L, Yang S-C, Liu T-Y, Wong F-H. The Interaction of Glycine N-methyltransferase and Carcinogens- (Benzo[a]pyrene and Aflatoxin B1) in Liver Cancer Cells. Annual Meeting of Chinese Society of Oncology, Taipei, April 1999.
    278. Chen YM. Molecular epidemiology of HIV-1 and HTLV-I in Taiwan. Invited speaker at the Branch of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA, Feb. 2000.
    279. Chen YM. Molecular epidemiology and Trends of HIV-1 infection in Taiwan. Invited speaker at the Year 2000 Taipei Symposium on the Clinical Management and Laboratory Diagnosis of AIDS. Taiepi, April 2000.
    280. Chen YM. Anti-Tat antibody and subtype E have synergistic effect on the sexual transmission of HIV-1. XIII International AIDS Conference. (Oral) Durban, South Africa, July 2000.
    281. Chen YM, Chen LY, Lin JR, Liu TY, Yang-Feng TL. Genomic Structure, Chromosomal Localization and Functional Study of the Human Glycine N-methyltransferase Gene. The 50th Annual Meeting of American Society of Human Genetics. Philadelphia, USA, Oct. 2000.
    282. Tseng TL, Chen YM, Struewing JP, Buetow K. Identification and characterization of novel polymorphisms/mutation in the glycine N-methyltransferase gene in liver cancer. The 50th Annual Meeting of American Society of Human Genetics. Oct. Philadelphia, USA, 2000.
    283. Chen YM. Functional study and characterization of novel polymorphisms of GNMT gene in liver cancer patients. In the “Recent advanced diagnosis and treatment in HCC meeting” held by the Chinese Society of Clinical Oncology, Dec. 2000.
    284. Chen YM, Chung CL, Wu SI, Hsu H. An HIV and STD Prevention Program for Men Attending Gay Saunas in TaipeiCity. 2001 Hong Kong AIDS Meeting. August 2001.
    285. Chen YM, Chung CL, Jen I, Lan YC, Wu SI, Hsu H. Surveys on the HIV-1, syphilis and sexual behavior among men attending gay saunas in Taipei City. The 6th ICAAP in Melbourne, Australia, Oct. 2001.
    286. Chen YM, Lei WY, Huang YC, Wu SI. The seroconversion of anti-Vpu antibody is associated with the recovery of humeral immunity in patients on highly active antiretroviral therapy. The 6th ICAAP in Melbourne, Australia, Oct. 2001.
    287. Tseng TL, Chen YM, Shih YP, Buetow KH. Genotypic and phenotypic characterization of a putative tumor suppressor gene, GNMT, in liver cancer. The 51st Annual Meeting of American Society of Human Genetics. San Diego, USA, Oct 2001.
    288. Chen YM, Lee CM, Shih YP, Tseng TL, Buetow K. Delineation of mechanism of glycine N-methyltransferase gene control in liver cancer. The 51st Annual Meeting of American Society of Human Genetics. San Diego, USA, Oct 2001.
    289. Shih YP, Huang YC, Tseng TL, Chen YM. A Study of the Glycine N-methyltransferase Genotypic and Phenotypic Characterization in Human Heptoma Cell Lines. The 35th Annual Meeting of Chinese Society of Microbiology, Taipei, Dec. 2001.
    290. Chen SY, Wong FH, Liu TY, Chen YM. A Study of the Interaction between 4S-PAH-binding Protein (GNMT) and Benzo[a]pyrene. The 35th Annual Meeting of Chinese Society of Microbiology, Taipei, Dec. 2001.
    291. Lee CM, Chen YM. A Study of the Mechanism of the Human GNMT Gene Control in Hepatocellular Carcinoma. The 35th Annual Meeting of Chinese Society of Microbiology, Taipei, Dec. 2001.
    292. Elbeik E, Lan YC, Dileanis JA, Marlowe N, Ng V, ChenYM. Prevalence of HIV-1 genotypic mutations in the protease and reverse transcriptase genes from infected individuals in Taiwan: Treatment challenges. The XIV International AIDS Conference, Barcelona, Spain, July, 2002.
    293. Jen I, Chen YM. Advocating a new health policy for mandatory condom distribution and nationwide behavior surveillance system establishment in Taiwan. The XIV International AIDS Conference, Barcelona, Spain, July, 2002.
    294. Hung CP, Wang WC, Jen I, Chen YM. Two-year consecutive survey of the prevalence rates of HIV and syphilis infection among men who have sex with men attending saunas in Taipei. The XIV International AIDS Conference, Barcelona, Spain, July, 2002.
    295. Chen YM, Elbeik E, Lan YC. Molecular epidemiology of HIV-1 subtypes and drug-resistant strains in Taiwan. The Third Annual HDR meeting. Virginia, 2002. (poster)
    296. Huang YC, Shih YP, Li CC, Liao LY, Chen YM. Characterization of Genetic Polymorphism of Glycine N-Methyltransferase Gene in Hepatocellular Carcinoma. 4th volume of Hormonal Carcinogenesis. The 4th International Symposium on Hormonal Carcinogenesis, Spain, Jun. 2003.
    297. Lan YC, Elbeik T, Lai SF, Chen KT, Leu HS, Cheng S H, Wong W W, Wong J C, Chen YM. Molecular Epidemiology of HIV-1 Subtypes and Drug Resistant Strains in Taiwan: The resurgence of HIV-1 subtype B in Taiwan during 1999 to 2000 survey. The XV International AIDS Conference, BangkokThailand, July 2004.
    298. Lin YT, Hsieh SL, Chen YJ, Lai SF, Chen YM. The serum level of the decoy receptor 3 (DcR3) is associated with HIV-1 subtype and AIDS disease progression. (oral presentation) The XV International AIDS Conference, BangkokThailand, July 2004.
    299. Lai SF, Hong CP, Lan YC, Chen KT, Wong WW, Hu BS, Chen YM. Molecular epidemiology of HIV-1 in men who have sex with men from gay saunas in Taiwan from 2000 to 2003. The XV International AIDS Conference, BangkokThailand, July 2004.
    300. Chen YM, Lan YC, Yang JY et al., Molecular epidemiology of SARS coronavirus infections in Taiwan. 2004 International Symposium on the Prevention and Control of SARS and Avian Flu. Beijing, China, August 22 to 24, 2004.
    301. Chen YM. Molecular epidemiology of HIV-1 and SARS infections in Taiwan. (Keynote speech) The 6thGuangdong, Hong Kong, Macau and Taiwan Conference on Preventive Medicine. Macau, Oct. 30, 2004.
    302. Lin YT, Hsieh SL, Chen YJ, Lai SF, Chen YM. The serum level of the decoy receptor 3 (DcR3) is associated with HIV-1 subtype and AIDS disease progression. The 6thGuangdong, Hong Kong, Macau and Taiwan Conference on Preventive Medicine. Macau, Oct. 30, 2004.
    303. Huang YC, Shih YP, Li CC, Liao LY, Chen YM. Characterization of genetic polymorphism of Glycine N-Methyltransferase gene in prostate cancer. The 6thGuangdong, Hong Kong, Macau and Taiwan Conference on Preventive Medicine. Macau, Oct. 30, 2004.
    304. Huang YC, Shih YP, Li CC, Liao LY, Chen YM. Characterization of genetic polymorphism of Glycine N-Methyltransferase gene in prostate cancer. The 54th Annual Meeting of American Society of Human Genetics. Toronto, Canada, Oct. 2004.
    305. Hsieh JL, Huang CY, Sun CT, Chen YM. Using the CAMIM small-world epidemic model to analyze public health policies. Western Multiconference 2005.
    306. Tsai TT Tsai, Chuang PH, Lin IF, Chen YM, Wu WH, Chang HJ, Chuang JH. Using Claims Data for Establishing a Syndromic Surveillance System in TaipeiCity. In International Association for Computer Information Systems Conference. 2005.
    307. Chen SY, Lee CM, Liu HH, Darbha R, Hsieh LL and Chen YM. Glycine N-methyltransferase is a novel cytosolic receptor for aflatoxin B1 and it can prevent AFB1-DNA adducts formation. The Twentieth National Biomedical Combined Conference. Taipei, Taiwan, March 26-27, 2005.
    308. Huang YC, Chung MY, Chang YH, Huang JSW, Ho MTD, Pan CC Wu TL, Chen YM. Genetic polymorphism and expression of glycine N-methyltransferase (GNMT) gene in prostate cancer. The Twentieth National Biomedical Combined Conference. Taipei, Taiwan, March 26-27, 2005.
    309. Sumodhee C., Hsieh J.L., Sun C.T., Huang C.Y., and Chen YM. Impact of Social Behaviors on HIV Epidemic: A Computer Simulation View. In Proceedings of IEEE Computational Intelligence for Modelling Control and Automation (CIMCA’2005), Vienna, Austria.
    310. Medah Isaie, Lai SF, Chang YU, Li CC, Kang HF, and Chen YM. Knowledge, attitude, and practices towards HIV/AIDS among first-year university students in Taiwan-A National Survey. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    311. Chen YM, Lai SF, Lan YC, Chen KH, Chen YJ. Molecular epidemiology of HIV-1 infection among injecting drug users in Taiwan-Report of an emergent situation. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    312. Wang CC, Wong WW, Chen YM. The effect of HAART on the disease progression of HIV/AIDS patients co-infected with HBV or HCV. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    313. LinYT, Chen YJ, Lai SF, Hsieh SL, Chen YM. Serum decoy receptor 3 (DcR3) level is associated with HIV-1 subtype B and slower AIDS disease progression. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    314. Tsui JJ , Lai SF, Chen YM, Wong WW, Yang SY. A Study of the Holistic Care Model for HIV/AIDS patients. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    315. Chang YR, Medah Isaie, Lai SF, Kang FH, and Chen YM. Advocacy for establishment of a guideline for the management of Students Living with HIV/AIDS at schools in Taiwan. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    316. Chang JL, Chen YM, KoNY. Help PLWHAs Being Familiar to Medical Care Systems: The HAART Partnership of Living with Hope Organization in Taiwan.  7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    317. LeeYM, LaiSF, Chen KD, Wong WW, ChenYM. Molecular Epidemiology of Hepatitis C Virus Subtypes in HIV/AIDS Patients in Taiwan. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    318. Lai SF, LanYC, Lin YH, ChenKT, WongWW, Chen YM. Molecular epidemiology of HIV-1 infection in men who have sex with men (MSM) from gay saunas in Taiwan from 2003 to 2004. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    319. LanYC, Elbeik Tarek, LaiSF, ChenKD, LeuHS, ChengSH, Wong WW, WongJC, Chen YM. Molecular Epidemiology of HIV-1 Subtypes and Prevalence of HIV-1 Genotypic Drug Resistant Strains in Taiwan. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    320. HsuSC, LinSR, HaungHC, Wang CC, Chen YM. Display of AIDS memorial quilts and at-risk babies crib quilts to advocate MTCT program in Taiwan. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    321. Chang CJ, WangCC, Chen YM. Use CD4 Counts, HBV and HCV Tests to Enhance the Participation and Effects of AIDS Education among PLWHAs in Prisons. 7th International Congress on AIDS in Asia and the Pacific, Kobe, Japan, July. 2005.
    322. Chen YM. Molecular epidemiology of HIV-1 infection among injecting drug users in Taiwan. 2005 Taipei International Conference on Drug Control and Addition Treatment. Taipei, Taiwan, November 22-24, 2005.
    323. Lee CM, Chen SY, Huang CYF, Lee YCG, Chen YM. Benzo[a]pyrene and Glycine N-Methyltransferse Interactions: Gene Expression Profiles of the Liver Detoxification Pathway. The 9th Asian-Pacific Conference on Transcription, ACT-IX. December. December 15-17, 2005.
    324. Chen YM. Establishment of a transgenic mouse model to study the interaction between GNMT and aflatoxin B1. 5th NHRI Conference on Viral Hepatitis and Hepatocellular Carcinoma. Chu-nan, Taiwan. March 24-25, 2006.
    325. Chen YM. HIV-1 drug resistance surveillance of treatment naïve persons in a clinical network. Antiretroviral Resistance Prevention, Surveillance and Monitoring in Asia World Health Organization, Global AIDS Program – Vietnam and Asia Regional Global AIDS Program. Hanoi, Vietnam March 27-31, 2006.
    326. Hsieh JL, Huang CY, Sun CT, Chen YM, Chu D. Using the Agent-based Epidemic Simulation CAMIM to Assess Public Health Policies. 2006 Mexican International Conference on Artificial Intelligence. Mexico.
    327. Lan YC, Lin YT, Chen JJ, Liu TT, Chen YM. Phylogenetic and genomic analyses of six full-length CRF07_BC variants isolated from injecting drug users in Taiwan. XVI International AIDS Conference, Toronto, Canada. (abstract No. CDA0118)
    328. Jang YR, Jiang YH, Chuang SY, Zhou J, Lan YC, Wong WW, Chen YM. Taiwan HIV observational database: baseline and retrospective data. XVI International AIDS Conference, Toronto, Canada. (abstract No.
    329. Chen YJ, Huang YH, Lan SF, Chen YM. Phylogenetic analysis of Taiwanese HIV-1 CRF08_BC strains: tracing the origin and dissemination of this CRF in Taiwan. XVI International AIDS Conference, Toronto, Canada. (abstract No.
    330. Hung KC, Chen YM. AIDS education combined with a display of AIDS memorial quilts to raise awareness among teenagers in Taiwan. XVI International AIDS Conference, Toronto, Canada. (abstract No.
    331. Zhou J, Dore G, Chen YM, Law M. Hepatitis B and C virus coinfection among patients with HIV in Asia HIV observational database. XVI International AIDS Conference, Toronto, Canada. (abstract No. TUAB0302, oral presentation)
    332. Chang KC, Chang CC, Mai CK, Jung KC, Chen YM. Development and implementation of a harm reduction and AIDS education program in the detention centers and prisons in Taiwan. XVI International AIDS Conference, Toronto, Canada. (abstract No. THPE0732, poster presentation).
    333. Chen YM, Huang YH, Chen CJ, Lai SF, Yang JY, Kuo HS. Molecular epidemiology of HIV-1 inTaiwan: emergence of CRF07_BC among injecting drug users in Taiwan. XVI International AIDS Conference, Toronto, Canada. (abstract No. MOPE0359. poster presenation)
    334. Chen YM. Molecular epidemiology of HIV-1 Subtypes and Circulating Recombinant Forms in Taiwan. Taiwan-Japan Conference on Infectious Disease Control, Taipei, 2006.
    335. Chen YM. Molecular epidemiology of HIV-1 Subtypes in Taiwan. 8th International Taipei AIDS conference. Taipei, 2006.
    336. Chen YM. Molecular epidemiology of HIV-1 Subtypes in Taiwan. Taiwan Medical Week. Invited speaker. Taipei, Nov. 13, 2006.
    337. Liu SP and Chen YM. Characterization of a GNMT gene knockout mouse model. 8th Meeting of Liver Cancer Study Group of Taiwan. Kaohsiung, Taiwan, Dec. 9, 2006.
    338. Tsai TI, Chen YM, Yang SY, Huang YF, Kuo HEvaluating preliminary harm reduction programs in Taiwan. 18th International Conference on the HR. Warsaw, Poland, May13-17
    339. Chen YM, Lin YT, Lan YC, Chen YJ, Huang YH, Lee CM, Liu TT, Wang CT. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BCstrains frominjecting drug users in Taiwan. Conference on HIV Pathogenesis, Treatment and Prevention. 4th IAS Conference on HIV Pathogenesis and Treatment, Sydney, Australia, 22-25 July 2007. (Poster)
    340. Jang YR, Zhou J, Chung SY, Wong WW, Chen YM. Prognostic markers related to AIDS diagnoses and deaths among HIV-1/AIDS patients in Taiwan. Conference on HIV Pathogenesis, Treatment and Prevention. 4th IAS Conference on HIV Pathogenesis and Treatment, Sydney, Australia, 22-25 July 2007. (Poster)
    341. Chang KC, Chang ZX, Huang CK, Chen JW and Chen YM. Development and implement of an outreach and Peer education program in NSP station in Taiwan. 8th International Congress on AIDS in Asia and the Pacific, Sri Lanka, August 19-23, 2007.
    342. Chen YM, Lin YT, Lan YC, Chen YJ, Huang YH, Lee CM, Liu TT, Wang CT. Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BCstrains frominjecting drug users in Taiwan. 8th International Congress on AIDS in Asia and the Pacific, Sri Lanka, 2007. (oral presentation).
    343. Chen YM. Molecular epidemiology of HIV-1 and HCV infections in Taiwan. International Conference on AIDS and TB. Taipei, 2007. (Invited speaker).
    344. Liu SP, Li YS, Chen YJ, Chiang EP, Li FY, Lee YH, Tsai TF, Hsiao M, Chen YM. Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in liver. The 57th ASHG, San Diego, California. Oct. 23, 2007.
    345. Chen YM. Serological and genetic correlates of SARS coronavirus infection. 2007 International Symposium on Humanity Care in the Post-SARS Era. Nov. 21-22, 2007. (Invited speaker).
    346. Chen YM. HIV-1 infection and harm reduction program in Taiwan. 21st Japanese Society for AIDS Research Annual Meeting, Hiroshima, Nov30, 2007. (Invited speaker).
    347. Chen YM. Searching for kinases and phosphatases associated with interaction between GNMT and DEPDC6 using RNAi screen. Taiwan –Broad Institute Joint Mini-symposium on RNAi Screen. (invited speaker), Taipei, May, 2008.
    348. Lan YC, Lu CL, KH, Chen YM. Impact of a Harm Reduction Program on the Prevention of HIV-1 Infection among Injecting Drug Users in Taiwan. (poster) 19th International Harm Reduction Association Conference, Spain, May, 2008.
    349. Lan YC and Chen YM. Evaluation of the harm reduction program in Taiwan. XVII International AIDS Conference, Mexico Coty, 3-8 August 2008 (oral presentation).
    350. Liao YJ and Chen YM. Glycine N-methyltransferase is associated with gender disparity in liver cancer susceptibility. 2008 Meeting on Mechanisms & Models of Cancer. ColdSpringHarbor Laboratory, NY, August 13-17, 2008. (Poster)
    351. Lee YM, Lee CM and Chen YM. Molecular epidemiology of HIV and HCV infection among injection drug users in Taiwan. XVII International AIDS Conference, Mexico Coty, 3-8 August 2008 (Poster).
    352. YR Chang, WW Wang and Chen YM. Clinical epidemiology of HIV-1 infection in Taiwan. XVII International AIDS Conference, Mexico Coty, 3-8 August 2008 (Poster).
    353. Chen YM. Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma. International Symposium in Regeneration Medicine. August 22, 2008, Taipei, Taiwan (oral).
    354. Chen YM, YJ Liao, SP Liu, TF Tsai. Glycine N-methyltransferase is associated with gender disparity in liver cancer susceptibility. 2nd International Liver Cancer Association Annual Conference. Chicago, September 5-7, 2008 (Poster).
    355. Lyu SY, Peng EY, Chen YM, Morisky DE, Cheng SH. Potential causes of rapid increase of HIV infection among injection drug users after SARS outbreak in Taiwan. (Poster) presented at the 9th Taipei international conference on HIV/AIDS, Taipei, Taiwan, 2008 (Poster).
    356. Lee YM, Lin HJ, Chen YJ, Lee CM, Wang SF, Chang KY, Chen TL, Liu HF, Chen YM. Molecular Epidemiology of HCV Genotypes among Injection Drug Users in Taiwan: Identification of a new subtype 6v and unique recombinant form_2b6v. 11th Western Pacific Congress on Chemotherapy and Infectious Diseases. (WPCCID), November 29-December 3, Taipei, Taiwan (Poster).
    357. Liao CF, Wang SF, Chen YM. Analysis of the DC-SIGN-interactive domains on the envelop glycoprotein of HIV-1 CRF07_BC. 11th Western Pacific Congress on Chemotherapy and Infectious Diseases. (WPCCID), November 29-December 3, Taipei, Taiwan (Poster).
    358. Hui E, Kumarasamy N, Choi JY, Merati T, Chen YM, Zhang F, Lim PL, Kerr S, Grulich A, Law M. AIDS and non-AIDS cancer diagnoses in the TREAT Asia HIV Observational Database (TAHOD): A retrospective analysis. WPCCID, Singapore. Dec 2010. (oral presentation).
    359. Yen CH and Chen YM. Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect. 100th AACR meeting, April 18-22, Denver, 2009. (poster).
    360. Chen M, Huang YC, Ko IL, Yang S, Chang YH, Huang W J-S, Chen YMA. Association study of rs1447295 at 8q24 with prostate cancer in Taiwanese men. World Chinese Urological Society Meeting. Chicago, April 2009. (oral presentation).
    361. Jan YR, Zhou J, Chuang SY, Wong WW, Chen YM. Impact of HBV and HCV coinfection on the Outcomes of antiretroviral treatment (ART) and disease progression in HIV-infected Patients in Taiwan. IAS (International AIDS Society Meeting), July 19-22, 2009.
    362. Chen YM, Chu YT, Kao DYT, Chiang SC, Wu SC. Risk of cancer among people living with HIV/AIDS (PLWHA) in Taiwan 1997-2007. 9th ICAAP, August 8-13, Bali, Indonesia.
    363. Chen YM. Network of collaborating universities in health care and its education. EAIE (European Association for International Education, oral presentation and section organizer, Madrid, Spain, September 14-20, 2009.
    364. Peng EY, Lyu SY, Morisky DE, Lan YC, Chen YM. Comparison of drug-using experiences among female inmates by age groups in Taiwan. 137 APHA (American Public Health Association) meeting, Philadelphia, USA, November 7-11, 2009.
    365. Yang YC, Chen YM, Yeh CC, Ling MP, Wang RY, Lu CL, Chen KH, Lai JS, Lan YC. Creating a HIV-1 infection risk model as a prevention tool for Injecting drug users. Comparison of drug-using experiences among female inmates by age groups in Taiwan. 137 APHA (American Public Health Association) meeting, Philadelphia, USA, November 7-11, 2009.
    366. Chen YM, Lan YC, Lyu SY. Evaluating the impact of harm-reduction program in Taiwan from 2005-2008. 137 APHA (American Public Health Association) meeting, Philadelphia, USA, November 7-11, 2009.
    367. Sirisanthana T, Kiertiburanakul S, Chen YM, HanN, Lim PL, KumarasamyN, Choi JY, Merati TP, Yunihastuti E, Law M. Trand of CD4 cell count in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment. ASHM. Oct 2010. (oral presentation).
    368.  Lee YM, Chen YJ, Chen YM. Molecular epidemiology of HCV infection among HIV-1-infected IDU in Taiwan: identification of a new subtype 6w. (poster) 17th Conference of Retrovirology and Opportunistic Infection (CROI), February 16-19, 2010.
    369. Oyomopito R, Phanuphak P, Sungkanuparph S, Kumarasamy N, Sirisanthana T, Li P, Chen YM. Cohort Profile: The TREAT Asia Studies to Evaluate Resistance Monitoring Study (TASER‑M) - HIV Drug Resistance in the Asia-Pacific. IAS Meeting, Vienna, Austria, July, 2010.
    370. Chen YM,Chu YT, Kao DYT, Chiang SC, Law M, Sharp G, Wu SC. Risk of Cancer among People Living with HIV/AIDS (PLWHA) in Taiwan 1997-2007. IAS Meeting, Vienna, Austria, July, 2010.
    371. Lan YC, Chen YM. Transmission origin of HIV-1 CRF01_AE and B subtype among injecting drug user in Taiwan. 138th APHA Annual Meeting, Denver, CO. Nov. 6-10, 2010.
    372. Chen YM, Lin YT Lee YM, Chen YJ, Wang SF.Molecular Epidemiology of HIV-1 and HCV Infection in Taiwan and the Development of Most Sensitive Diagnostic Methods to Detect SARS Corona Virus and H1N1 Viruses. 9th Guangdong, Hong Kong, Macau and Taiwan Preventive Medicine Conference, 2010. (invited speaker).
    373. Chen YM.Characterization of a Glycine N-methyltransferase Gene Knockout Mouse Model for Hepatocellular Carcinoma and Neuropsychiatric disorder.Regenerative Medicine 2010: From Stem Cells to Disease Models, Taipei. (invited speaker)
    374. Yang CP, SuNY, Wang HA, Tsai TH, Chen CJ, Hong CJ, Yang UC, Chen YM. Characterization of the Neuropsychiatric Phenotype and Gene Expression Profile of Gnmt Knockout Mice. 2010 Frontiers in Neuroscience: From Genes to Cognition, Taipei. (poster)
    375. Liu YH, Peng WC, Ju YT, Wu SC, Sharp GB,Kuo KN and Chen YM. A study on the Incidence of Malignancy in a Taiwanese HIVAIDS Patient Cohort using National Health Insurance database. CROI. Boston, 2011. (poster).
    376. Liu YH, Peng WC, Ju YT, Wu SC, Sharp GB,Kuo KN and Chen YM. A study on the Incidence of Malignancy in a Taiwanese HIVAIDS Patient Cohort using National Health Insurance database. Int AIDS Society IAS Meeting. Rome, 2011. (poster).
    377. Lin YT, Szu-Wei Huang SW, Wang CT, Kuritzkes DR, Chen YM. Virological Characterization of HIV-1 Circulating Recombinant Form (CRF) 07_BC Strains from Injection Drug Users in Taiwan. Int AIDS Society IAS Meeting. Rome, 2011. (poster).
    378. 藍郁青, Norman Kok, 楊依蓁, 呂嘉麗, 陳冠樺, 呂淑妤,陳宜民.女性注射藥癮者其感染HIV-1之危險因子、認知與態度研究.台灣公共衛生年會、台灣流行病學學會暨台灣事故傷害預防與安全促進學會聯合年會, 2010.
    379. Yen CH, Lu YC, Li CH, Chen CY, Cheng MY, Huang SF, Chen FF, Cheng AL, Liao LY, Lee WU YH, Chen YM. GNMT expression activates mTOR/Raptor signaling but delays G2/M progression in hepatocellular carcinoma. Taiwan Digestive Diseases Week, 2011. (oral presentation).
    380. Clinical epidemiology of cancer in HIV-1/AIDS patients in Taiwan. Annual TREAT Asia meeting, Chiang-Mai, Thailand, 2011. (Invited speaker).
    381. Clinical epidemiology of tuberculosis infection in HIV-1/AIDS patients in Taiwan. Annual TREAT Asia meeting, Chiang-Mai, Thailand, 2011. (Invited speaker).
    382. Li CH, Yen CH, Chen MY, Chen YM. Activation of PI3K pathway by P-Rex2 is inhibited by GNMT. The 13th SCBA International Symposium. Guangzhou, China. July 2011.
    383. Yen CH, Chen YM. GNMT activates mTOR/Raptor signaling and delays G2/M progression through interacting with DEPTOR. The AACR 102nd Annual Meeting. Orlando, USA. 2011.
    384. Lu YC, Yen CH, Lai XT, Chen YM. Phosphorylation of serine 9 is required for benzo(a)pyrene induced GNMT nuclear translocation. The AACR 102nd Annual Meeting. Orlando, USA. 2011. (poster)
    385. Yen CH, Chen YM. GNMT activates mTOR/Raptor signaling and delays G2/M progression through interacting with DEPTOR. 13th Society of Chinese Bioscientists in America (SCBA) International Symposium, Guangzhou, China. 2011. (poster)
    386. Lu YC, Yen CH, Lai XT, Chen YM. Phosphorylation of serine 9 is required for benzo(a)pyrene induced GNMT nuclear translocation. 13th Society of Chinese Bioscientists in America (SCBA) International Symposium, Guangzhou, China. 2011. (poster)
    387. Li CH, Yen CH, Chen YM. Activation of PI3K pathway by P-RRex2 is inhibited by GNMT. 13th Society of Chinese Bioscientists in America (SCBA) International Symposium, Guangzhou, China. 2011. (poster)
    388. Yen CH, Huang SF, Chen KF, Cheng AL, Liao LY, Chen YM. GNMT expression activates mTOR/Raptor signaling but delays G2/M progression in hepatocellular carcinoma. 2011 Taiwan Digestive Disease Week Satellite Symposium. Taipei, Taiwan. 2011. (Oral presentation).
    389. Lin YT, Lan YC, Chen YJ, Lee YM, Chen YM. Molecular Epidemiology of HIV-1 Infection in Taiwan. The 2011 Annual Meeting of Taiwan AIDS Society, Taipei, 22 January 2011 (Oral).
    390. Lin YT, Huang SW, Wang CT, Kuritzkes DR, Chen YM. Virological Characterization of HIV-1 Circulating Recombinant Form (CRF) 07_BC Strains from Injection Drug Users in Taiwan. The 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, Rome, Italy, 17-20 Jul 2011. (E-Poster)
    391. Lin YT, Huang SW, Wang CT, Kuritzkes DR, Chen YM. Virological Characterization of HIV-1 Circulating Recombinant Form (CRF) 07_BC Strains from Injection Drug Users in Taiwan. Society of Chinese Bioscientists in America (SCBA) 13th International Symposium, Guangzhou, China, 25-29 Jul 2011 (Poster).
    392.  Liao YJ, Lee TS, Wang CK, Huang SF, Chen YM. Glycine N-Methyltransferase Deficiency Affects Niemann-Pick Type C2 Protein Stability and Involves in the Pathogenesis of Fatty Liver. International Liver Cancer Association Fifth Annual Conference, Hong Kong, September, 2011.
    393. Lin YT, Lee YM, Chuang SY, Chen YJ, Wang SF, Liu HF, Chen YM. Molecular Epidemiology of Human Herpesvirus Type 8 and Parvovirus B19 Infections and Their Association with HIV-1 among Men Having Sex with Men and Injection Drug Users in Taiwan. XIX International AIDS Conference, WashingtonDC, USA, 22-27 Jul 2012 (Poster).
    394. Li CH, Yen CH, Chen MY, Tseng PH, Chen YM. Activation of PI3K pathway by P-Rex2 is inhibited by GNMT. The AACR 103rd Annual Meeting. Chicago, USA. Mar-Apr. 2012.
    395. Chen YJ, Lee YM, Chen M, Chuang SY, Liu HF, Wong WW, Lin YH, Tsai HC, Wang JH and Chen YM. Molecular Epidemiology of HIV-1 Infection in Taiwan: Further Spread of CRF07_BC and the emergence of Dual Infection. XIX International AIDS Conference, Washington DC, 2012.
    396. Liao YJ, Wang CK, Chen YM. Glycine N-Methyltransferase interacts with Niemann-Pick Type C2 and regulates the progression of steatohepatitis. 101 The Gastroenterological Society of Taiwan. Tri-Service General Hospital, Taipei, March, 2012.
    397. Fang CC, Liao YJ, Chen YM. Glycine N-methyltransferase deficiency affects hepatic cholesterol homeostasis and steatosis associated inflammation. America Association for Cancer Research, 103rd Annual Meeting, Chicago, USA April, 2012.
    398. Yen CH, Lu YC, Li CH, Huang SF, Chen YM. Characterization of the Functions of Glycine N-methyltransferase (GNMT) and its Interactive Protein-DEPTOR in the Pathogenesis of Hepatocellular Carcinoma. PTEN Pathways & Targets meeting. ColdSpringHarbor. NY, USA. 2012. (poster).
    399. Chen YM. Glycine N-methyltransferase (GNMT) animal model and use thereof. TechConnect World Summit, Expo and Showcase 2012, Santa Clara, CA, USA, June 2012 (oral).
    400. Chen YM. Molecular epidemiology of HIV and HCV infection in Taiwan. Sino Microbiologist meeting, 2012, San Francisco, USA. (oral).
    401. Li CH, Chu SH, Huang JC, Chen YM. A study of the function of GNMT in the T cell response in experimental autoimmune encephalomyelitis. ColdSpringHarbor Asia Meeting, Suzhou, China, 2012. (oral).
    402. Fang CC, Liao YJ, Chen YM. Functional Characterization of Glycine N-methyltransferase in Steatosis-associated Inflammation. Annual United Biomedical Sciences Meeting, Taipei, April, 2013. (poster).
    403. Huang SW, Lin YT, Hung CP, Chen YH, Yang JY, Lin SR, Chen YM. Risk Factors Associated with HIV-1 Infection among Men who Have Sex with Men in Taiwan in 2012. IAS meeting, KL, Malaysia, 2013.

Editors and Reviewers:

Associate Editor:

Biomedical Central (BMC)-Infectious Disease (since 2008);

Biomedical Central (BMC)-Research Note (since 2008).

Journal of Integrated Omics (since 2013)

Editorial board member:

The Open Hepatology Journal (since 2008)

Liver Cancer Review Letters (since 2009)

World Journal Hepatology (2009-2013)

World Journal of Clinical Case (since 2012)

Chinese Journal of Medicine (since 2008)

Newsletter for Research on Applied Ethics (since 2000, in Chinese)

Journal of Advanced Technology and Management (since 2011, in Chinese)


Patents


Publications

Referred papers: (*corresponding author)

Identification of FKBP11 as a biomarker for hepatocellular carcinoma. Anticancer Res., 33: 2763-2769, 2013.

     Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study. PLoS One. 2014 May 6;9(5):e94683. doi: 10.1371/journal.pone.0094683. eCollection 2014.

Book Chapters

Chinese articles:


Television or Movies Interviews

CDC, 愛在擁抱, 2008

國科會,認識病毒, 2008

Asian Harm Reduction Association, 台灣愛滋減害成效報導 (在2009 International Harm Reduction Conference 播出)

公共電視 有話好說 新型流感病毒專輯2009-4-27

公共電視 有話好說 新型流感病毒專輯2009-4-29

公共電視 有話好說 新型流感病毒專輯2009-4-30

民視 新聞最前線2009-5-2

年代電視 真情台灣 愛滋器官移植事件的省思2011-9-8

公共電視 NGO觀點 勇抱愛滋,愛之擁抱. 2012-12-6


Invited seminar


Conference Abstracts

Go to top